| 1 |
A Balanced Protein Supplement Fortified with Essential Vitamins , Minerals & DHA |
Each 30g contains:
Protein Hydrolysate 20%
DHA 10 %
Pyridoxine Hydrochloride Cyanocobalamin Vitamin D3
Folic Acid Niacinamide Calcium
(as Dibasic Calcium Phosphate Dihydrate IP) Manganese Sulphate
Zinc
(as ZincSulphate Heptahydrate IP)
Iron
(as Ferric Ammonium Citrate IP) Magnesium Oxide
Cupric Sulphate Chromium
(as Chromium Chloride USP) Selenium Dioxide Monohydrate Potassium Chloride
Sodium Chloride
Iodine (as Potassium Iodide IP) Excipients |
IP IP IP IP IP
USP
IP USP
USP IP IP |
5 g
25 mg
0.5 mg
1 mcg
100 IU
0.3 mg
15 mg
200 mg
1.5 mcg
1.5 mg
10 mg
4 mg
2.5 mg
25 mcg
20 mcg
5 mg
33 mg
100 mcg q.s. |
| 2 |
Abalanced Protein Supplement Fortified with Essential Vitamins & Minerals |
Each 30gmpowder Contains Whey Protein 30%
Docosa HexaenoicAcid 10 % Pyridoxine Hydrochloride Cyanocobalamin
Vitamin D3 Folic Acid Niacinamide Calcium
(as Dibasic Calcium Phosphate Dihydrate IP) Manganese Sulphate
Zinc
(as ZincSulphate Heptahydrate IP)
Iron
(as Ferric Ammonium Citrate IP) Magnesium Oxide
Cupric Sulphate Chromium
(as Chromium Chloride USP) Selenium Dioxide Monohydrate Potassium Chloride
Sodium Chloride Iodine
(as Potassium Iodide IP) Excipients |
IP IP IP IP IP
USP
IP USP
USP IP IP |
10 g
25 mg
0.5 mg
1 mcg
100 IU
300 mcg
15 mg
200 mg
1.5 mcg
1.5 mg
10 mg
4 mg
2.5 mg
25 mcg
20 mcg
5 mg
33 mg
100 mcg q.s. |
| 3 |
Acebrophylline & Acetylcysteine Tablets |
Each film coated Tablet Contains: Acebrophylline
Acetylcysteine Excipients
Approved colour used. |
BP |
100mg 600mg q.s. |
| 4 |
Acebrophylline & N- Acetyl L- Cysteine Tablets |
Each film coated Tablet Contains: Acebrophylline
N- Acetyl L-Cysteine Excipients
Approved colour used |
BP |
100mg 600mg q.s. |
| 5 |
Acebrophylline & N- Acetyl L- Cysteine Tablets |
Each film coated Bilayered Tablet Contains: Acebrophylline
N- Acetyl L-Cysteine Excipients
Approved colour used |
BP |
100mg 600mg q.s. |
| 6 |
Acebrophylline Sustained Release Tablets |
Each film coated sustained release Tablet contains : Acebrophylline Excipients Approved colour used |
|
200mg q.s. |
| 7 |
Aceclofenac & DrotaverineTablets |
Each Film Coated Tablet Contains: Aceclofenac
Drotaverine Hydrochloride Excipients
Colour : Approved Colour Used |
IP IP |
100mg 80mg q.s. |
| 8 |
Aceclofenac & Paracetamol Tablets |
Each Uncoated Tablets Contains:
Aceclofenac Paracetamol Excipients
Approved colour used (Aceclofenac
ParacetamolFinished Product and Raw Material in Amendent 2024) |
IP IP |
100 mg
325 mg q.s. |
| 9 |
Aceclofenac & Serratiopeptidase Tablets |
Each filmcoated tablet contain: Aceclofenac
Serratiopeptidase
( Eq. to enzyme activityof 20000 units of enteric coated granules)
Excipients
Approved colour used |
IP IP |
100 mg
10 mg
q.s. |
| 10 |
Aceclofenac & Serratiopeptidase Tablets |
Each film coated Tablet Contains: Aceclofenac
Serratiopeptidase
(Eq. to enzyme activityof 30000 units of enteric coated granules)
Excipients
Approved colour used. |
IP IP |
100mg 15mg
q.s. |
| 11 |
Aceclofenac & Thiocolchicoside Tablets |
Each Film Coated Tablet Contains: Aceclofenac
Thiocolchicoside Excipients
Colour : Approved Colour Used |
IP IP |
100mg 4mg q.s. |
| 12 |
Aceclofenac & Thiocolchicoside Tablets |
Each Film Coated Tablet Contains: Aceclofenac
Thiocolchicoside Excipients
Colour : Approved Colour Used |
IP IP |
100mg 8mg q.s. |
| 13 |
Aceclofenac along with Linseed oil, Menthol, Methyl Salicylate & Capsaicin |
Composition :- Aceclofenac Linseed Oil Menthol
Methyl Salicyclate Capsaicin
Banzyl Alcohol (as Preservative) Gel base |
IP BP IP IP USP IP |
1.5%w/w 3%w/w 5%w/w 10%w/w 0.010%w/w
1%w/w q.s. |
| 14 |
Aceclofenac Sustained Release Tablets |
Each Film Coated Tablet Contains :
Aceclofenac
(As Sustained Release) Excipients
Colour : Approved Colour Used |
IP |
200mg q.s. |
| 15 |
Aceclofenac Tablets |
Each film coated Tablets Contains : Aceclofenac
Excipients
Approved colour used. |
IP |
100mg q.s. |
| 16 |
Aceclofenac,
Paracetamol, Caffeine, Phenylephrine HCL & Cetirizine Hydrochloride Tablets |
Each uncoated tablet contains:
Aceclofenac Paracetamol
Phenylephrine Hydrochloride
Cetirizine Hydrochloride Caffeine(Anhydrous) Excipients
Approved colour used |
IP
IP IP
IP IP |
100 mg
325 mg
5 mg
10 mg
25 mg q.s. |
| 17 |
Aceclofenac, Paracetamol & Chlorzoxazone Tablet |
Each Film Coated Tablet Contains Aceclofenac
Paracetamol Chlorzoxazone Excipients
Approved colour used |
IP IP USP
q.s. |
100 mg
325 mg
250 mg |
| 18 |
Aceclofenac, Paracetamol & Chlorzoxazone Tablets |
Each Film coated Tablet Contains: Aceclofenac
Paracetamol Chlorzoxazone Excipients
Approved colour used |
IP IP USP |
100mg 325mg 500mg q.s. |
| 19 |
Aceclofenac, Paracetamol & Chymotrypsin Tablets |
Each Film coated Tablets Contains:
Aceclofenac Paracetamol
Trypsin Chymotrypsin
50000 Armour unit of enzymaticactivity
(Supplied bya purified concentrate which has specific Trypsin and chymotrypsin activity in ratio of Approximate six to one) Excipients
Approved colour used |
IP IP |
100 mg
325 mg
50000 AU
q.s. |
| 20 |
Aceclofenac, Paracetamol & Serratiopeptidase Tablets |
Each film coated Tablet Contains: Aceclofenac
Paracetamol Serratiopeptidase
(Eq. to enzyme activityof 30000 units of enteric coated granules)
Excipients
Approved Colour Used. |
IP IP IP |
100mg 325mg 15mg
q.s. |
| 21 |
Aceclofenac, Paracetamol & Serratiopeptidase Tablets |
Each film coated Tablet Contains: Aceclofenac Paracetamol Serratiopeptidase (Eq. to 20,000 Serratiopeptidase units)Excipients Approved Colour Used. |
IP IP IP |
100mg 325mg 10mg q.s |
| 22 |
Aceclofenac, Paracetamol & Thiocolchicoside Tablet |
Each Film Coated Tablet Contains Aceclofenac
Paracetamol Thiocolchicoside Excipients
Approved colour used |
IP IP
q.s. |
100 mg
325 mg
4 mg |
| 23 |
Aceclofenac, Paracetamol & Thiocolchicoside Tablet |
Each Film Coated Tablet Contains Aceclofenac
Paracetamol Thiocolchicoside Excipients
Approved colour used |
IP IP
q.s. |
100 mg
325 mg
8 mg q.s. |
| 24 |
Aceclofenac, Paracetamol Tablets |
Each Film coated Tablets Contains: Aceclofenac
Paracetamol Excipients
Approved colour used |
IP IP |
100 mg
325 mg q.s. |
| 25 |
Aceclofenac, Paracetamol, Phenylephrine HCL, Cetirizine HCL & Caffeine Tablets |
Eachuncoated tablet contains: Aceclofenac Paracetamol Phenylephrine HCL Cetirizine HCL CaffeineAnhydrous |
IP IP IP IP IP |
100mg 325mg 10mg 5mg 25mg q.s. |
| 26 |
Aciclovir Dispersible Tablet IP |
Each uncoated tablet contains: Aciclovir
Excipients
Approved colour used |
IP |
800 mg |
| 27 |
Aciclovir Tablet IP |
Each uncoated tablet contain: Aciclovir
Excipients
Approved colour used |
IP |
800 mg q.s. |
| 28 |
Acyclovir Dispersible Tablets IP |
Each uncoated Tablets Contains: Acyclovir
Excipients
Approved colour used |
IP |
400 mg q.s. |
| 29 |
Albendazole
Oral Suspension IP |
Each 5ml contains: Albendazole Excipients
Approved colour used |
IP |
200mg q.s. |
| 30 |
Albendazole & Ivermectin Tablet |
Each Uncoated tablet contains: Albendazole
Ivermectin Excipients
Colour :- Approved colour used |
IP IP |
400mg 6mg q.s. |
| 31 |
Albendazole Tablet IP |
Each Uncoated Chewable Tablet Contains:- Albendazole
Excipients
Colour:- Approved Colour used |
IP |
400mg q.s. |
| 32 |
Allopurinol Tablets IP |
Each uncoated tablets contains: Allopurinol
Excipients
Approved colour used |
IP |
100 mg q.s. |
| 33 |
Allopurinol Tablets IP |
Each uncoated tablets contains: Allopurinol
Excipients
Approved colour used |
IP |
300 mg q.s. |
| 34 |
Alprazolam Tablets IP |
Each uncoated tablet contains: Alprazolam
Excipients
Approved colour used |
IP |
0.25 mg q.s |
| 35 |
Alprazolam Tablets IP |
Each uncoated tablet contains: Alprazolam
Excipients
Approved colour used |
IP |
0.5 mg q.s |
| 36 |
Ambroxol Hydrochloride (SR)&
Levocetirizine hydrochloride Tablets |
Each Film coated Tablet Contains:-
Ambroxol Hydrochloride (As sustained Release) Levocetirizinehydrochloride Excipients
Approved colour used |
IP IP |
75 mg
5mg q.s. |
| 37 |
Ambroxol Hydrochloride & Cetirizine Hydrochloride
Syrup |
Each 5ml contains : Ambroxol Hydrochloride Cetirizine Hydrochloride In a Flavoured SyrupyBase.
Approved colour used |
IP IP |
30mg 5mg q.s. |
| 38 |
Ambroxol Hydrochloride, Terbutaline Sulphate & Guaiphenesin oral
Drops |
Each ml(Approx. 20drops) contains : Ambroxol Hydrochloride Terbutaline Sulphate
Guaiphenesin
In a flavoured syrupyBase. Approved colour used. |
IP IP IP |
7.5mg 0.5mg 12.5mg q.s. |
| 39 |
Amisulpride Tablets IP |
Each Uncoated Tablet Contains: Amisulpride
Excipients
Approved colour used. |
IP |
100mg q.s. |
| 40 |
Amitriptyline Hydrochloride Tablets IP |
Each film coated tablet contains:- Amitriptyline Hydrochloride Excipients
Colour:- Approved Colour used |
IP |
10 mg q.s. |
| 41 |
Amitriptyline Hydrochloride Tablets IP |
Each film coated tablet contains:- Amitriptyline Hydrochloride Excipients
Colour:- Approved Colour used |
IP |
25 mg q.s. |
| 42 |
Amitriptyline Hydrochloride Tablets IP |
Each film coated tablet contains:- Amitriptyline Hydrochloride Excipients
Colour:- Approved Colour used |
IP |
50 mg q.s. |
| 43 |
Amlodipine & Atenolol Tablets |
Each uncoated tablet contains:- Amlodipine Besylate Equivalent to Amlodipine Atenolol
Excipients
Colour:- Approved colour used |
IP IP |
5 mg
50 mg q.s. |
| 44 |
AmlodipineTablets IP |
Each uncoated tablet contains:- Amlodipine Besylate Equivalent to Amlodipine Excipients
Colour : Approved Coloured Used |
IP |
5 mg q.s |
| 45 |
AmlodipineTablets IP |
Each uncoated tablet contains:- Amlodipine Besylate Equivalent to Amlodipine Excipients
Colour : Approved Coloured Used |
IP |
10 mg q.s |
| 46 |
AmlodipineTablets IP |
Each uncoated Tablet contains: Amlodipine Besylate
Equ. To Amlodipine Excipients
Approved colour used. |
IP |
2.5mg q.s. |
| 47 |
Artemether & Lumifantrine Tablets |
Each uncoated Tablets Contains: Artemether
Lumifantrine Excipients
Approved colour used |
IP |
80 mg
480 mg q.s. |
| 48 |
Ascorbic Acid (Vitamin C ), Sodium Ascorbate & Zinc Chewable Tablets |
Each uncoated Tablet Contains: Ascorbic Acid
Sodium Ascorbate Equ. To Ascorbicacid Zinc
Excipients
Approved Colour Used |
IP IP |
100mg 450mg 400mg 5mg q.s |
| 49 |
Ascorbicacid Tablet IP |
Each Uncoated Chewable Tablet Contains Ascorbic acid
Excipients
Colour : Approved Colour Used |
IP |
500mg |
| 50 |
Atenolol Tablets IP |
Each Uncoated Tablet Contains: Atenolol
Excipients
Colour : Approved Coloured Used |
IP |
50mg q.s |
| 51 |
Atenolol Tablets IP |
Each Uncoated Tablet Contains: Atenolol
Excipients
Colour : Approved Coloured Used |
IP |
100mg q.s |
| 52 |
Atorvastatin & FinofibrateTablets |
Each filmcoated tablet contain Atorvastin Calcium
Eq.to Atorvastin Finofibrate Excipients
Approved colour used |
IP IP |
10 mg
160 mg q.s. |
| 53 |
Atorvastatin Tablets IP |
Each film coated tablet contains:- Atorvastatin Calcium
Eq. to Atorvastatin Excipients
Colour:- Approved colour used |
IP |
10 mg q.s. |
| 54 |
Atorvastatin Tablets IP |
Each film coated tablet contains:- Atorvastatin Calcium
Eq. to Atorvastatin Excipients
Colour:- Approved colour used |
IP |
20 mg q.s. |
| 55 |
Atorvastatin Tablets IP |
Each film coated tablet contains:- Atorvastatin Calcium
Eq. to Atorvastatin Excipients
Colour:- Approved colour used |
IP |
40 mg q.s. |
| 56 |
Atorvastatin Tablets IP |
Each film coated tablet contains:- Atorvastatin Calcium
Eq. to Atorvastatin Excipients
Colour:- Approved colour used |
IP |
80 mg q.s. |
| 57 |
Azathioprine Tablets IP |
Each uncoated tablet contains: Azathioprine
Excipients
Approved colour used. |
IP |
50mg q.s. |
| 58 |
Azithromycin & Lacticacid Bacillus Tablet |
Each film coated tablet contains: Azithromycin Dihydrate
Equ. to Azithromycin Anhydrous Lactic acid Bacillus
Excipients
Approved colour used |
IP |
250mg 60 million spores q.s |
| 59 |
Azithromycin & Lacticacid Bacillus Tablet |
Each film coated tablet contains: Azithromycin Dihydrate
Equ. to Azithromycin Anhydrous Lactic acid Bacillus
Excipients
Approved colour used |
IP |
500mg 60 million spores q.s |
| 60 |
Azithromycin Dispersible Tablet |
Each uncoated dispersible Tablet Contains : Azithromycin Dihydrate
Equ. To Azithromycin anhydrousExcipients
Colour : Approved Coloured Used |
IP |
100mg |
| 61 |
Azithromycin Tablet IP |
Each film coated tablet contains: Azithromycin Dihydrate
Equivalent to Azithromycin anhydrous Excipients
Approved colour used |
IP |
250 mg q.s. |
| 62 |
Azithromycin Tablet IP |
Each film coated tablet contains: Azithromycin Dihydrate
Equivalent to Azithromycin anhydrous Excipients
Approved colour used |
IP |
500 mg q.s. |
| 63 |
Baclofen Tablets IP |
Each uncoated tablet contains:
Baclofen Excipients
Approved colour used. |
IP
. |
10mg q.s. |
| 64 |
Baclofen Tablets IP |
Each uncoated tablet contains:- Baclofen Excipients Approved colour used. |
IP |
25mg q.s |
| 65 |
Beclomethasone Dipropionate, Phenylephrine Hydrochloride & Lignocaine Hydrochloride
Cream |
Composition: Beclomethasone Dipropionate Phenylephrine Hydrochloride Lignocaine Hydrochloride Preservative Chlorocresole Aqueous cream base |
IP IP IP IP |
0.025%w/w
0.10% w/w
2.50% w/w
0.1% w/w q.s. |
| 66 |
Betahistine Tablet (SR) IP |
Each uncoated sustainedrelease tablet contain: Betahistine Hydrochloride
Excipients
Approved colour used |
IP |
24 mg q.s. |
| 67 |
Betahistine Tablet IP |
Each Uncoated Tablet Contains:- Betahistine hydrochloride Excipients
Approved colour used |
IP |
8mg q.s. |
| 68 |
Betahistine Tablet IP |
Each Uncoated Tablet Contains:- Betahistine hydrochloride Excipients
Approved colour used |
IP |
16 mg q.s. |
| 69 |
Betahistine Tablets IP |
Each uncoated tablets contains: Betahistine Hydrochloride Excipients
Approved colour used |
IP |
8 mg q.s. |
| 70 |
Betahistine Tablets IP |
Each uncoated tablets contains: Betahistine Hydrochloride Excipients
Approved colour used |
IP |
16 mg q.s. |
| 71 |
Betahistine Tablets IP |
Each uncoated Tablet contains: Betahistine Hydrochloride Excipients
Approved colour used. |
IP |
24mg q.s. |
| 72 |
Betamethasone Tablets IP |
Each uncoated tablet contains:- Betamethasone
Excipients
Colour : Approved Coloured Used |
IP |
0.5mg q.s. |
| 73 |
Bilastine & Montelukast Tablets |
Each Film Coated bilayered tablet Contains: Montelukast Sodium eq. to
Montelukast Bilastine Excipients
Approved colour used. |
IP |
10mg 20mg q.s. |
| 74 |
Bilastine Tablets |
Each Film Coated Tablet Contains: Bilastine
Excipients
Approved colour used |
|
20mg q.s. |
| 75 |
Biotin & FolicAcid Tablets |
Each film coated Tablet contains: Biotin
Folic Acid Excipients
Approved Colour used |
USP IP |
5mg 5mg q.s |
| 76 |
Biotin Tablets USP |
Each Film coated Tablet Contains : Biotin
Excipients
Approved colour used |
USP |
10mg q.s. |
| 77 |
Bisacodyl Tablets IP |
Each enteric coated tablet contains:
Bisacodyl
Excipients
Approved colour used |
IP |
5mg q.s. |
| 78 |
Bisoprolol Fumarate Tablets |
Each film coated tablet contains:
Bisoprolol Fumarate Excipients
Approved colour used. |
IP |
2.5mg q.s. |
| 79 |
Bisoprolol Fumerate Tablets |
Each film coated tablet contains:
Bisoprolol Fumerate
Excipients
Approved colour used. |
IP |
5mg q.s. |
| 80 |
Calcium & Vitamin D3 Tablets IP |
Each Film coated Tablet Contains : Calcium Carbonate
Equ. toElemental Calcium Vitamin D3
Excipients
Approved Colour Used. |
IP IP |
500mg 250IU
q.s. |
| 81 |
Calcium Carbonate & Vitamin D3 Tablets |
Each film coated Tablet contains: Calcium Carbonate (Derived from an organicsource oyster shell) Equ. To Elemental Calcium Vitamin D3 "Excipients Approved colour used." |
IP IP |
1250mg 500mg 500IU q.s. |
| 82 |
Calcium Carbonate, Vitamin D3, Methylcobalamin, L-Methylfolate Calcium & Pyridoxal-5- Phosphate Tablets |
Each Film Coated Tablet Contains : Calcium Carbonate( from Oyster shell) Equ. To Elemental Calcium
Vitamin D3 Methylcobalamin
L- Methylfolate Calcium Pyridoxal-5- Phosphate Excipients
Approved colour used. |
IP IP |
1250mg 500mg 2000IU
1500mcg 1mg 20mg q.s. |
| 83 |
Calcium Citrate Maleate, Calcitriol , Folic Acid , Zinc & Vitamin K2-7 Tablets |
Each Film Coated Tablet Contains: Calcium Citrate Maleate
Equ. ToElemental CalciumCalcitriol Folic Acid
Zinc Sulphate Monohydrate
Equ. To Zinc Vitamin K2-7 Excipients
Approved colour used |
IP IP IP |
250mg 0.25mcg 100mcg
7.5mg 50mcg q.s. |
| 84 |
Calcium Citrate Maleate, Methylcobalamin, Vitamin D3, Vitamin K2-7, Magnesium Oxide & Zinc Oxide Tablets |
Each film coated tablet contains: Calcium Citrate Maleate Methylcobalamin
Vitamin D3 Vitamin k2-7 Zinc Oxide Magnesium Oxide Excipients
Approved colour used |
IP IP
IP IP |
1250mg 1500mcg 1000IU
90mcg 15mg 50mg q.s. |
| 85 |
Calcium Citrate Maleate& Vitamin D3 Tablets |
Each film coated Tablet Contains: Calcium Citrate Maleate
Equ. ToElemental CalciumVitamin D3 Excipients
Approved colour used |
USP IP |
1250mg 250mg 450IU
q.s. |
| 86 |
Calcium Citrate, Calcitriol
,
Zinc & Manganese Tablets |
Each film coated tablet contains: Calcium Citrate
Calcitriol
Zinc Sulphate Monohydrate Eq. to elemental Zinc
Manganese (as Manganese Sulphate) Excipients
Approved colour used. |
USP BP IP
IP |
1000 mg
0.25 mcg
7.5 mg
40 mg
q.s. |
| 87 |
Calcium Citrate, Magnesium, Zinc With Vitamin D3 Tablets |
Each film coated Tablet Contains: Calcium Citrate
Magnesium Hydroxide Zinc Sulphate Monohydrate Equ. to Elemental Zinc Vitamin D3
Excipients
Approved Colour Used. |
USP IP IP
IP |
1000mg 100mg
4mg 200IU
q.s. |
| 88 |
Calcium Orotate & Vitamin D3 Tablets |
Each film coated tablet contains: Calcium Orotate Vitamin D3 (Stabilized) Excipients Approved colour used. Appropriate overages of vitamin added to compensate the loss on storage. |
IP |
740mg 1000 IU q.s. |
| 89 |
Calcium Pantothenate Tablets I.P. 200mg |
Each film coated tablet contains: D-Calcium Pantothenate Excipients Approved colour used. |
IP |
200mg q.s. |
| 90 |
Calcium,VitaminD3, Methylcobalamin,L- Methylfolate Calcium & Pyridoxal-5- Phosphate Tablets |
Each film coated tablet contains:
Calcium Carbonate eq.to Elemental Calcium Vitamin D3 Mecobalamin (Methylcobalamin)
L-Methylfolate calcium Pyridoxal-5-Phosphate Excipients
Approved colour used. |
IP
IP IP |
1250mg 500mg 2000 I.U.
1500mcg
1mg 20mg q.s. |
| 91 |
Carbamazepine Tablets IP |
Each uncoated tablet contains:- Carbamazepine
Excipients
Colour:- Approved Colour used |
IP |
200 mg q.s. |
| 92 |
Carbimazole Tablets IP |
Each Film coated Tablet Contains : Carbimazole
Excipients
Approved colour used |
IP |
5mg q.s. |
| 93 |
Carisoprodol Tablets IP |
Each Uncoated tablet contains:- Carisoprodol
Excipients
Colour:- Approved Colour used |
IP |
350 mg q.s |
| 94 |
Carvedilol Tablets IP |
Each film coated Tablet contains: Carvedilol
Excipients
Approved colour used |
IP |
3.125mg
q.s. |
| 95 |
Carvedilol Tablets IP |
Each uncoated Tablet Contains: Carvedilol
Excipients
Approved colour used |
IP |
12.5mg q.s. |
| 96 |
Carvedilol Tablets IP |
Each Uncoated Tablet contains: Carvedilol
Excipients
Approved colour used |
IP |
6.25mg q.s. |
| 97 |
Carvedilol Tablets IP |
Each Uncoated Tablet contains: Carvedilol
Excipients
Approved colour used |
IP |
3.125mg
q.s. |
| 98 |
Cetirizine Dihydrochloride, Dextromethorphan Hydrobromide & Phenylephrine Hydrochloride
Syrup |
Each 5ml contains : Dextromethorphan Hydrobromide Cetirizine Dihydrochloride Phenylephrine Hydrochloride
In a flavoured SyrupyBase Approved colour Used |
IP IP IP |
10mg 5mg 5mg q.s. |
| 99 |
Cetirizine Hydrochloride & Ambroxol Hydrochloride Tablets |
Each film coated tablet contains: Cetirizine Hydrochloride Ambroxol Hydrochloride Excipients Approved colour used. |
IP IP |
5mg 60mg q.s. |
| 100 |
Cetirizine Hydrochloride Tablets IP |
Each uncoated tablet contains:- Cetirizine Hydrochloride Excipients
Colour:- Approved Colour used |
IP |
10 mg q.s. |
| 101 |
Chlordiazepoxide & Clidinium Bromide Tablet |
Each Film Coated tablet contains Chlordiazepoxide
Clidinium Bromide Excipients
Approved Colour used |
IP IP |
5mg 2.5mg q.s |
| 102 |
Chlorpheniramine Maleate tablet IP |
Each Uncoated Tablet Contains: Chlorpheniramine Maleate
Equ. To
Chlorpheniramine Excipients |
IP |
4mg q.s. |
| 103 |
Chlorpromazine Hydrochloride Tablets IP |
Each film coated tablet contains:- Chlorpromazine Hydrochloride Excipients
Colour:- Approved Colour used |
IP |
50 mg q.s. |
| 104 |
Chlorpromazine Hydrochloride Tablets IP |
Each film coated tablet contains:- Chlorpromazine Hydrochloride Excipients
Colour:- Approved Colour used |
IP |
100 mg q.s. |
| 105 |
Chlorpromazine Hydrochloride Tablets IP |
Each film coated Tablet Contains: Chlorpromazine Hydrochloride Excipients
Approved colour used. |
IP |
50mg q.s. |
| 106 |
Chlorzoxazone, Diclofenac Potassium, Paracetamol |
Each film coated tablet contains: Chlorzoxazone
Diclofenac Potassium Paracetamol Excipients
Approved colour used. |
USP BP IP |
250mg 50mg 325mg q.s. |
| 107 |
Cholecalciferol oral solution USP |
Each ml Contains: Cholecalciferol (Vitamin D3)
In a pleasantlyflavoured palatable Base Approved Colour used. |
IP |
400IU
q.s. |
| 108 |
Cholecalciferol Tablet IP |
Each uncoated chewable tablet contains Cholecalciferol (Stabilized) Excipients
Colour :- Approved colour used |
IP |
60000IU
q.s. |
| 109 |
Cholecalciferol, Ferrous Ascorbate, Folic Acid & Cyanocobalamin Tablets |
Each film coated Tablet Contains: Cholecalciferol
Ferrous Ascorbate Equ. ToElemental IronFolic Acid Cyanocobalamin Excipients
Approved colour used |
IP
IP IP |
1000IU
100mg 1mg 7.5mcg q.s. |
| 110 |
Cilnidipine Tablet |
Each film coated tablet contains Cilnidipine
Excipients
Colour :- Approved Colour Used |
IP |
10mg q.s |
| 111 |
Cilnidipine Tablets IP |
Each film coated tablet contains:
Cilnidipine
Excipients
Approved colour used. |
IP |
5mg q.s. |
| 112 |
Cilnidipine Tablets IP |
Each film coated tablet contains: Cilnidipine
Excipients
Approved colour used. |
IP |
5mg q.s. |
| 113 |
CilnidipineTablets IP |
Each film coated Tablet contains: Cilnidipine
Excipients
Approved colour used. |
IP |
20mg q.s. |
| 114 |
Cilostazol Tablets IP |
Each uncoated tablet contains:
Cilostazol Excipients
Approved colour used. |
IP |
50mg q.s. |
| 115 |
Cilostazol Tablets IP |
Each uncoated tablet contains:
Cilostazol Excipients
Approved colour used. |
IP |
100mg q.s. |
| 116 |
Cinnarizine (SR)Tablet IP |
Each uncoatedtablet contain:
Cinnarizine
(As Sustained Release) Excipients
Approved colour used |
IP |
75 mg q.s. |
| 117 |
Cinnarizine and Dimenhydrinate Tablets |
Each uncoated Tablet contains: Cinnarizine
Dimenhydrinate Excipients
Approved Colour used |
IP BP |
20mg 40mg q.s |
| 118 |
Cinnarizine Tablet IP |
Each uncoated tablet contain: Cinnarizine
Excipients
Approved colour used |
IP |
25 mg q.s. |
| 119 |
Cinnarizine Tablets IP |
Each uncoated Tablet contains Cinnarizine
Excipients
Approved Coloured used |
IP |
75mg q.s |
| 120 |
Cinnarizineand Domperidone Tablets |
Each uncoated Tablets Contains: Cinnarizine
Domperidone Excipients
Approved colour used |
IP IP |
20 mg
15 mg q.s. |
| 121 |
Ciprofloxacin and Tinidazole Tablets |
Each film coated Tablet contains: Ciprofloxacin Hydrochloride Equ. To Ciprofloxacin Tinidazole
Excipients
Approved colour used |
IP IP |
250mg 300mg q.s |
| 122 |
Ciprofloxacin Tablets IP |
Each film coated tablet contains:- Ciprofloxacin Hydrochloride Eq. tociprofloxacin
Excipients
Colour:- Approved colour used |
IP |
250 mg q.s. |
| 123 |
Ciprofloxacin Tablets IP |
Each film coated tablet contains:- Ciprofloxacin Hydrochloride Eq. tociprofloxacin
Excipients
Colour:- Approved colour used |
IP |
500 mg q.s. |
| 124 |
Citicoline & PiracetamTablets |
Each Film coated Tablets Contains: Piracetam
Citicoline sodium Equivalent to Citicoline Excipients
Approved colour used |
IP IP |
800 mg
500 mg q.s. |
| 125 |
Citicoline Tablets |
Each Film coated Tablets Contains: Citicoline sodium
Equivalent to Citicoline Excipients
Approved colour used |
IP |
500 mg q.s. |
| 126 |
Clarithromycin Tablet IP |
Each film coated tablet Contains :- Clarithromycin
Excipients
Colour :- Approved colour used |
IP |
250mg q.s. |
| 127 |
Clarithromycin Tablet IP |
Each film coatedtablet contain: Clarithromycin
Excipients
Approved colour used |
IP |
500 mg q.s |
| 128 |
Clomifene Tablets IP |
Each uncoated tablet contains:
Clomifene Citrate Excipients
Approved colour used. |
IP |
50mg q.s. |
| 129 |
Clomiphene Citrate Tablets IP |
Each Uncoated Tablet Contains: Clomiphene Citrate
Excipients |
IP |
50mg q.s. |
| 130 |
Clomiphene Tablet IP |
Each uncoated Tablet Contains :- Clomiphene Citrate
Excipients
Colour :- Approved colour used |
IP |
50mg q.s |
| 131 |
Clonazepam Tablet IP |
Each uncoated Tablet contains: Clonazepam
Excipients
Approved colour used |
IP |
0.25mg q.s |
| 132 |
Clonazepam Tablet IP |
Each uncoated Tablet contains: Clonazepam
Excipients
Approved colour used |
IP |
0.5mg q.s |
| 133 |
Clopidogrel Bisulphate Tablet |
Each film coated Tablet Contains: Clopidogrel Bisulphate
Equ. toClopidogrel Excipients
Colour : Approved Coloured Used |
IP |
75mg q.s |
| 134 |
Combikit of Azithromycin Tablet IP, Fluconazole Tablet IP & Secnidazole Tablet IP |
Each Combikit Contain: q) Azithromycin Tablet IP (1 Tablet)Each film coated tablet contain: Azithromycin Dihydrate Equivalent to Azithromycin anhydrous Approved colour used B) FluconazoleTablet IP (1 Tablet) Each uncoated tablet contain: Fluconazole Approved colour used C) SecnidazoleTablet IP(2Tablet) Each film coated tablet contain: Secnidazole Approved colour used |
IP IP IP |
1 gm 150 mg 1 gm |
| 135 |
Cyproheptadine Hydrochloride Tablet IP |
Each uncoated tablet contains : - Cyproheptadine Hydrochloride (as anhydrous)
Excipients
Colour : Approved Colour Used |
IP |
4mg q.s |
| 136 |
Cyproheptadine Tablet IP |
Each uncoated tablet contains: Cyproheptadine Hydrochloride (Anhydrous) Excipients
Approved colour used |
IP |
4 mg |
| 137 |
Dapagliflozin & Metformin HCl (ER) Tablets |
Each film coated Tablet Contains : Dapagliflozin Propanedial Monohydrate Equ. To Dapagliflozin
Metformin Hydrochloride (as Extended Release) Excipients
Approved colour used |
IP |
10mg 1000mg
q.s. |
| 138 |
Dapagliflozin 10mg & Metformin HCl (ER) 500mg
Tablets |
Each film coated Tablet Contains : Dapagliflozin Propanedial Monohydrate Equ. To Dapagliflozin
Metformin Hydrochloride (as Extended Release) Excipients
Approved colour used |
IP |
10mg 500mg
q.s. |
| 139 |
Dapagliflozin Tablets |
Each film coated tablet contain: Dapagliflozin propanediol monohydrate Eq. to Dapagliflozin
Excipients
Approved colour used |
|
5 mg q.s |
| 140 |
Dapagliflozin Tablets |
Each film coated tablet contain: Dapagliflozin propanediol monohydrate Eq. to Dapagliflozin
Excipients
Approved colour used |
|
10 mg q.s |
| 141 |
Dapoxetine Tablets IP |
Each film coated tablet contains: Dapoxetine Hydrochloride Equ. To Dapoxetine
Excipients
Approved colour used |
IP |
30 mg q.s |
| 142 |
Dapoxetine Tablets IP |
Each film coated tablet contains: Dapoxetine Hydrochloride Equ. To Dapoxetine
Excipients
Approved colour used |
IP |
60 mg q.s |
| 143 |
Deflazacort Tablet |
Each uncoated tablet contain: Deflazacort
Excipients
Approved colour used |
|
30 mg q.s. |
| 144 |
Deflazacort Tablets |
Each Uncoated Tablet Contains: Deflazacort
Excipients
Approved Colour used |
|
18mg q.s |
| 145 |
Deflazacort Tablets |
Each uncoated tablet contains: Deflazacort
Excipients
Colour:- Approved colour used |
IP |
12 mg q.s. |
| 146 |
Desloratadine Tablet |
Each film coated Tablet Contains:- Desloratadine
Excipients
Approved colour used |
BP |
5 mg q.s. |
| 147 |
Dexamethasone Tablets IP |
Each uncoated tablet contains:- Dexamethasone
Excipients
Colour : Approved Coloured Used |
IP |
0.5 mg q.s. |
| 148 |
Dexketoprofen Tablet |
Each film coated Tablet Contains: Dexketoprofen trometamol
Equ. To Dexketoprofen Excipients
Colour : Approved Coloured Used |
|
25mg q.s |
| 149 |
Dextromethorphan HBR,
Chlorpheniramine Maleate, Phenylephrine HCL Tablets |
Each uncoated tablet Contains: Dextromethorphan Hydrobromide Chlorpheniramine Maleate Phenylephrine Hydrochloride Excipients
Approved colour used |
IP IP IP |
10 mg
2 mg
5 mg q.s. |
| 150 |
Dextromethorphan HBR, Bromhexine HCL &
Phenylephrine HCL Syrup |
Each 5 ml Contains: Dextromethorphan Hydrobromide Bromhexine Hydrochloride Phenylephrine Hydrochloride
In a flavoured syrupybase
Approved colour base |
IP IP IP |
5 mg
4 mg
5 mg q.s. |
| 151 |
Dextromethorphan Hydrobromide, Phenylephrine hydrochloride & Chlorpheniramine Maleate Tablets |
Each uncoated tablet contains : Dextromethorphan Hydrobromide Phenylephrine Hydrochloride Chlorpheniramine Maleate Excipients |
IP IP IP |
10mg 5mg 2mg q.s |
| 152 |
Diacerein , Glucosamine & Methylsulfonylmet hane Tablets |
Each film coated tablets contains: Diacerein
Glucosamine Sulphate potassium chloride Eq.to glucosamine Methylsulfonylmethane
Excipients
Approved colour used |
IP USP
USP |
50mg 750mg 446mg 250mg |
| 153 |
Diclofenac & TolperisoneTablets |
Each uncoated sustained releaseTablet contains: Tolperisone Hydrochloride
Diclofenac Sodium Excipients
Approved colour used |
IP |
450mg 100mg q.s. |
| 154 |
Diclofenac Paracetamol & Chlorzoxazone Tablets |
Each uncoated tablet contains:- Paracetamol
Diclofenac Potassium Chlorzoxazone Excipients
Colour:- Approved colour used |
IP BP USP |
325 mg
50 mg 250mg q.s. |
| 155 |
Diclofenac Potassium , Paracetamol & Serratiopeptidase Tablets |
Each film coated Tablet Contains:
Diclofenac Potassium Paracetamol Serratiopeptidase
( Eq. to enzyme activityof 20000 units of enteric coated granules)
Excipients
Approved Colour Used. |
BP IP IP |
50mg 325mg 10mg
q.s. |
| 156 |
Diclofenac Potassium , Paracetamol & Serratiopeptidase Tablets |
Each film coated Tablet Contains:
Diclofenac Potassium Paracetamol Serratiopeptidase
( Eq. to enzyme activityof 20000 units of enteric coated granules)
Excipients
Approved Colour Used. |
BP IP IP |
50mg 325mg 10mg
q.s. |
| 157 |
Diclofenac Potassium , Paracetamol & Serratiopeptidase Tablets |
Each film coated Tablet Contains:
Diclofenac Potassium Paracetamol Serratiopeptidase
( Eq. to enzyme activityof 30000 units of enteric coated granules)
Excipients
Approved Colour Used. |
BP IP IP |
50mg 325mg 15mg
q.s. |
| 158 |
Diclofenac Potassium & Metaxalone Tablets |
Each uncoated Tablet contains: Diclofenac Potassium Metaxalon Excipients Approved colour used. Remarks-New permission add on 14/02/2025 Sr.NO 924. |
BP |
50mg 400mg q.s. |
| 159 |
Diclofenac Potassium & Metaxalone Tablets |
Each uncoated tablet contains:- Diclofenac Potassium Metaxalone
Excipients
Approved colour used . |
IP USP |
50mg 400mg q.s. |
| 160 |
Diclofenac Potassium & Paracetamol Tablets |
Each film coated Tablet Contains: Diclofenac Potassium Paracetamol
Excipients
Approved colour used |
BP IP |
50mg 325mg q.s. |
| 161 |
Diclofenac Potassium & Paracetamol Tablets |
Each Uncoated Tablet Contains: Diclofenac Potassium Paracetamol
Excipients |
BP IP |
50mg 325mg q.s. |
| 162 |
Diclofenac Potassium & Serratiopeptidase Tablets |
Each film coated Tablet contains: Diclofenac Potassium Serratiopeptidase
(Eq. toenzyme activityof 30000units of enteric coated granules)
Excipients
Approved colour used. |
BP IP |
50mg 15mg
q.s. |
| 163 |
Diclofenac Potassium & Serratiopeptidase Tablets |
Each film coated tablet contains :
Diclofenac Potassium Serratiopeptidase
(as enteric coated 20,000 unit of activated enzymatic activity of Serratiopeptidase )
Excipients
Approved colour used. |
BP IP |
50mg 10mg
q.s. |
| 164 |
Diclofenac Potassium & Thiocolchicoside Tablets |
Each enteric coated tablet contains: Diclofenac Potassium Thiocolchiside Excipients Approved colour used. |
IP IP |
50mg 4mg q.s. |
| 165 |
Diclofenac Potassium Sustained Release Tablets |
Each film coated sustainedrelease tablet contains: Diclofenac Potassium
Excipients
Approved colour used |
BP |
100 mg q.s. |
| 166 |
Diclofenac Potassium Tablets IP |
Each Filmcoated Tablet contains: Diclofenac Potassium
Excipients
Approved colour used |
IP |
25mg q.s. |
| 167 |
Diclofenac Potassium, Paracetamol & Trypsin Chymotrypsin Tablets |
Each enteric coated tablet contains: Diclofenac Potassium
Paracetamol
Trypsin Chymotrypsin
50000 Armour unit of enzymatic activity. Excipients
Approved colour used. |
BP IP BP |
50mg 325mg 50000AU
q.s. |
| 168 |
Diclofenac Potassium, Paracetamol & Chlorzoxazone Tablets |
Each film coated Tablet Contains: Diclofenac Potassium Paracetamol
Chlorzoxazone Excipients
Approved colour used |
BP IP IP |
50mg 325mg 500mg q.s. |
| 169 |
Diclofenac potassium, Paracetamol & Chymotrypsin Tablets (Discontinue AFTER GETTING APPROVAL AS PER S.No.892
which is in enteric coated
formulation). |
Each Film coated Tablets Contains:
Diclofenac potassium Paracetamol
Trypsin Chymotrypsin
50000 Armour unit of enzymatic activity
(Supplied by a purified concentrate which has specific Trypsin and chymotrypsin activity in ratio of Approximate six to one) Excipients
Approved colour used |
BP IP |
50 mg
325 mg
50000 AU
q.s. |
| 170 |
Diclofenac Sodium
, Paracetamol & Chlorzoxazone Tablets |
Each uncoated tablet contains:- Paracetamol
Diclofenac Sodium Chlorzoxazone Excipients
Colour:- Approved colour used |
IP IP USP |
325 mg
50 mg 250mg q.s. |
| 171 |
Diclofenac Sodium & Paracetamol Tablets |
Each film coated tablets contains:
Diclofenac Sodium (as Enteric coated) Paracetamol Excipients
Approved colour used |
IP IP |
50mg 325mg |
| 172 |
Diclofenac Sodium & Paracetamol Tablets IP |
Each Uncoated Bilayered tablet contains : Diclofenac Sodium
Paracetamol Excipients
Approved colour used. |
IP IP |
50mg 325mg q.s. |
| 173 |
Diclofenac Sodium & Serratiopeptidase Tablets |
Each film coated Tablet Contains: Diclofenac Sodium Serratiopeptidase
(Eq. to enzyme activityof 20000 units of enteric coated granules)
Excipients
Approved Colour Used. |
IP IP |
50mg 10mg
q.s. |
| 174 |
Diclofenac Sodium SR Tablet IP |
Each film coated Sustained Release tablet Contains Diclofenac Sodium
Excipients
Colour :- Approved colour used |
IP |
100mg q.s |
| 175 |
Diclofenac Sodium Tablets IP |
Each Enteric Coated Tablet Contains: Diclofenac Sodium
Excipients
Approved Colour Used |
IP |
50mg q.s |
| 176 |
Diclofenac, Paracetamol and Serratiopeptidase Tablets |
Each film coated tablet contains:- Diclofenac Sodium
Paracetamol Serratiopeptidase
(Eq.to Enzyme activity30000 Units of enteric coated granules)
Excipients
Colour:- Approved colour used |
IP IP IP |
50 mg
325 mg
15 mg
q.s. |
| 177 |
Dicyclomine Hydrochloride& Paracetamol Tablets |
Each uncoated Tablet contains: Dicyclomine Hydrochloride Paracetamol
Excipients
Approved colour used |
IP IP |
20mg 500mg q.s. |
| 178 |
Digoxin Tablets IP |
Each Uncoated Tablet Contains: Digoxin
Excipients |
IP |
0.25mg q.s. |
| 179 |
Digoxin Tablets IP |
Each uncoated Tablet Contains: Digoxin
Excipients
Approved colour used |
IP |
0.25mg q.s. |
| 180 |
Disulfiram Tablets |
Each Uncoated Tablet Contains:- Disulfiram
Excipients
Colour :- Approved colour used |
IP |
200mg q.s |
| 181 |
Domperidone DispersibleTablets |
Each uncoated dispersible tablet contains: Domperidone
Excipients
Approved colour used |
IP |
10mg q.s |
| 182 |
Doxofylline ( Sustained Release) & Montelukast Tablets |
Each Filmcoated Bilayered Tablet Contains :
Doxofylline
(as Sustained Release) Montelukast Sodium Equ. To Montelukast Excipients
Approved colour used |
IP IP |
400mg
10mg q.s. |
| 183 |
Doxofylline & Ambroxol Hydrochloride Tablets |
Each Film coated Tablet Contains : Doxofylline
Ambroxol Hydrochloride Excipients
Approved colour used |
IP IP |
400mg 30mg q.s. |
| 184 |
Doxofylline Modified Release Tablets |
Each uncoated Modified Release Tablet contains : Doxofylline
Excipients |
IP |
650mg q.s. |
| 185 |
Doxofylline Tablets IP |
Each film Coated Tablet Contains :- Doxofylline
Excipients
Colour :- Approved colour used |
IP |
400mg q.s. |
| 186 |
Doxofylline Tablets IP |
Each uncoated Tablet Contains :- Doxofylline
Excipients |
IP |
400mg q.s. |
| 187 |
Doxofylline(SR) & Montelukast Sodium Tablets |
Each uncoated tablet contains: Doxofylline (As sustainedrelease) Montelukast Sodium Eq. to Montelukast |
IP IP |
400 mg10mg q.s. |
| 188 |
Doxycycline & Lactic Acid Bacillus Tablets |
Each Film coated Tablet Contains : Doxycycline Hyclate
Equ. To DoxycyclineLactic Acid Bacillus Excipients
Approved colour used |
IP |
100mg
5 Billion Spores q.s. |
| 189 |
Doxycycline Hyclate Tablets |
Each film coated Tablet Contains: Doxycycline Hyclate
Equ. To Doxycycline Excipients
Approved colour used. |
IP |
100mg q.s. |
| 190 |
Doxylamine Succinate & Pyridoxine HCl Tablets |
Each enteric coated tablet contains : Doxylamine Succinate
Pyridoxine Hydrochloride Excipients
Approved colour used |
USP IP |
10mg 10mg q.s |
| 191 |
Doxylamine succinate, Pyridoxine hydrochloride & Folicacid Tablets |
Each enteric coated tablets contains: Doxylamine succinate Pyridoxinehydrochloride
Folic acid Excipients
Approved colour used |
BP IP IP |
10 mg
10 mg
2.5 mg q.s. |
| 192 |
Doxylamine succinate, Pyridoxine hydrochloride & Folicacid Tablets |
Each enteric coated tablets contains: Doxylamine succinate Pyridoxinehydrochloride
Folic acid Excipients
Approved colour used |
USP IP IP |
20 mg
20 mg
5 mg q.s. |
| 193 |
Dried Aluminium Hydroxide, Magnesium Aluminium Silicate Hydrate, Magnesium Hydroxide & Simethicone Chewable Tablets |
Each uncoated Chewable Tablet Contains: Dried Aluminium Hydroxide
Magnesium Aluminium Silicate Hydrate Magnesium Hydroxide
Simethicone Excipients
Colour: Erythrosine & Ponceau 4R |
IP
IP IP |
300mg 50mg 25mg 25mg q.s |
| 194 |
Drotaverine hydrochloride & Mefenamic Acid Tablets |
Each film coated tablets: Drotaverine hydrochloride Mefenamic Acid Excipients
Approved colour used |
IP IP |
80 mg
250 mg q.s. |
| 195 |
Drotaverine Hydrochloride Tablet IP |
Each film coated tablet Contains :- Drotaverine Hydrochloride Excipients
Colour :- Approved colour used |
IP |
40mg q.s. |
| 196 |
Drotaverine Hydrochloride Tablets IP |
Each uncoated Tablet contains Drotaverine Hydrochloride Excipients
Approved Coloured used |
IP |
80mg q.s |
| 197 |
Drotaverine Hydrochloride Tablets IP |
Each Film coated Tablet contains Drotaverine Hydrochloride Excipients
Colour : Approved Coloured used |
IP |
80mg q.s |
| 198 |
Duloxetine Gastro- resistant Tablets IP |
Each enteric coated Tablet contains : Duloxetine Hydrochloride
Equ. To Duloxetine Excipients
Approved Colour used. |
IP |
20mg q.s. |
| 199 |
EbastineTablet IP |
Each film coated tablet contains: Ebastine
Excipients
Approved colour used |
IP |
10 mg q.s |
| 200 |
EbastineTablet IP |
Each film coated tablet contains: Ebastine
Excipients
Approved colour used |
IP |
20 mg q.s |
| 201 |
Empagliflozin & Linagliptin Tablets |
Each film coated tablet contains:- Empagliflozin Linagliptin Excipients Approved colour used . |
|
10mg 5mg q.s. |
| 202 |
Empagliflozin & Linagliptin Tablets |
Each film coated tablet contains:- Empagliflozin Linagliptin Excipients Approved colour used . |
|
25mg 5mg q.s. |
| 203 |
Erythromycin StearateTablet IP |
Each film coated Tablet Contains: Erythromycin Stearate
Equ. toErythromycin Excipients
Colour:- Approved colour used |
IP |
250mg |
| 204 |
Escitalopram Oxalate & Clonazepam Tablet IP |
Each film coated Tablet Contains:- Escitalopram Oxalate
Equivalent toEscitalopram Clonazepam
Excipient
Approved colour used |
IP IP |
10 mg
0.5 mg q.s. |
| 205 |
Escitalopram OxalateTablet |
Each film coated Tablet Contains: Escitalopram oxalate
Equ. toEscitalopram Excipients
Colour : Approved Coloured Used |
IP |
10mg q.s |
| 206 |
Esomeprazole Gastro?esistant Tablet IP |
Each Enteric coated Tablet contains :- Esomeprazole magnesium Trihydrate Equ. to Esomeprazole
Excipients
Colour : Approved Coloured Used |
IP |
40mg q.s. |
| 207 |
Etizolam Tablets |
Each film coated tablet contains: Etizolam
Excipients
Approved colour used |
|
0.25 mg q.s |
| 208 |
Etizolam Tablets |
Each film coated tablet contains: Etizolam
Excipients
Approved colour used |
|
0.5 mg q.s |
| 209 |
Etodolac Extended Release Tablets USP |
Each Film Coated Extended Release Tablet contains : Etodolac
Excipients
Approved colour used |
IP |
600mg q.s. |
| 210 |
Etodolac Tablets IP |
Each Film Coated Tablet contains: Etodolac
Excipients
Approved colour used |
IP |
400mg q.s. |
| 211 |
Etodolac Tablets IP |
Each Film Coated Tablet contains: Etodolac
Excipients
Approved colour used |
IP |
300mg q.s. |
| 212 |
Etophylline & Theophylline Prolonged Release Tablet IP |
Each Film coated prolonged release Tablet contains Etophylline
Theophylline Anhydrous Equ. To Theophyllinehydrate Excipients
Colour : Approved Coloured Used |
IP IP |
115mg
35mg q.s |
| 213 |
Etoricoxib & Paracetamol Tablets |
Each film coated tablet Contains:- Etoricoxib
Paracetamol Excipients
Colour :- Approved colour used |
IP IP |
60mg 325mg q.s |
| 214 |
Etoricoxib & Thiocolchicoside Tablets |
Each film coated tablet Contains:- Etoricoxib
Thiocolchicoside Excipients
Colour :- Approved colour used |
IP IP |
60mg 4mg q.s |
| 215 |
Etoricoxib and Pregabalin (Prolonged Release) Tablets |
Each uncoated bilayered tablet contains: Etoricoxib
Pregabalin
(As prolonged release) Excipients
Approved colour used. |
IP IP |
60 mg
75 mg q.s. |
| 216 |
Etoricoxib tablets IP |
Each film coated tablet contains:- Etoricoxib
Excipients
Colour:- Approved Colour Used |
IP |
90 mg q.s. |
| 217 |
Etoricoxib tablets IP |
Each film coated tablet contains:- Etoricoxib
Excipients
Colour:- Approved Colour Used |
IP |
60 mg q.s. |
| 218 |
Etoricoxib tablets IP |
Each film coated tablet contains:- Etoricoxib
Excipients
Colour:- Approved Colour Used |
IP |
120 mg q.s. |
| 219 |
Febuxostat Tablet |
Each film coated tablet contains: Febuxostat
Excipients
Approved colour used |
|
120 mg q.s |
| 220 |
Febuxostat Tablets |
Each film coated tablet contains:- Febuxostat
Excipients
Colour:- Approved colour used |
|
40 mg q.s. |
| 221 |
Febuxostat Tablets |
Each film coated tablet contains:- Febuxostat
Excipients
Colour:- Approved colour used |
|
80 mg q.s. |
| 222 |
Ferrous Ascorbate , Folic Acid & Zinc Tablet |
Each film coated Tablet Contains: Ferrous Ascorbate
Equ. toElemental Iron Folic Acid
Zinc Sulphate Monohydrate Equ. to Elemental Zinc Excipients
Approved Colour Used. |
IP IP |
100mg 1.5mg
22.5mg q.s. |
| 223 |
Ferrous Ascorbate , Folic Acid, Methylcobalamin & Zinc Sulphate Monohydrate Tablet |
Each Film Coated Tablet Contains: Ferrous Ascorbate
Equ. ToElemental IronFolic Acid Methylcobalamin
Zinc Sulphate Monohydrate Equ. To Elemental Zinc Excipients
Approved Colour Used |
IP
IP IP IP |
100mg 1.1mg 1.5mg
22.5mg q.s. |
| 224 |
Ferrous Ascorbate (SR) and L-Methylfolate Tablets |
Each film coated tablet contains: Ferrous Ascorbate Eq. to Elemental Iron (In sustained release form) Calcium L-5 Methyltetrahydrofolate Eq. to L-Methylfolate Excipients Approved colour used. Appropriate overages of L-Methylfolate added to compensate loss on storage. |
I.P. U.S.P q.s. |
100mg 0.5mg |
| 225 |
Ferrous Ascorbate & Folic Acid Tablets |
Each film coated tablet contains:- Ferrous Ascorbate
Eq.toElemental Iron Folic Acid Excipients
Colour:- Approved colour used |
IP |
100 mg
1.5 mg q.s. |
| 226 |
Ferrous Ascorbate, Folic Acid & Methylcobalamin Tablets |
Each film coated tablets contains: Ferrous Ascorbate Eq. to Elemental Iron Folic Acid Methylcobalamin Excipients Approved Colour used. Appropriate overages of vitamins added to compensate the loss on storage. |
I.P. I.P. |
100mg 1.5mg 1500 mcg qs |
| 227 |
Ferrous Ascorbate, Folic acid, Cyanocobalamin & Zinc Tablet |
Each film coatedtablet contain: Ferrous Ascorbate
Equ. toElmental Iron Folic acid
Zinc Sulphate Monohydrate Equ. To Elmental Zinc Cyanocobalamin Excipients
Approved colour used |
IP IP
IP |
100 mg 1.5mg
22.5mg 15mcg q.s |
| 228 |
Fexofenadine & Montelukast ChewableTablets |
Each Uncoated Chewable Tablet Contains : Fexofenadine Hydrochloride
Montelukast Sodium Equ. To Montelukast
Excipients |
IP IP |
120mg
10mg q.s. |
| 229 |
Fexofenadine & Montelukast Tablet |
Each uncoated Tablet contains Fexofenadine Hydrochloride Equ. to Fexofenadine Montelukast Sodium
Equ. to Montelukast Excipients
Colour : Approved Colour Used |
IP IP |
120mg
10mg q.s. |
| 230 |
Fexofenadine Hydrochloride & Montelukast Tablets |
Each film coated tablet contains: Fexofenadine Hydrochloride Montelukast sodium
Equ. To Montelukast Excipients
Approved colour used. |
IP IP |
120mg
10mg q.s. |
| 231 |
Fexofenadine Hydrochloride Tablet IP |
Each uncoated Tablet contains Fexofenadine Hydrochloride Equ. to Fexofenadine Excipients
Colour : Approved Colour Used |
IP |
120mg q.s. |
| 232 |
Fexofenadine Hydrochloride Tablets IP |
Each Film coated Tablets Contains: Fexofenadine Hydrochloride Excipients
Approved colour used |
IP |
180 mg q.s. |
| 233 |
Fexofenadine Hydrochloride Tablets IP |
Each film coated tablet contains: Fexofenadine Hydrochloride Excipients
Approved colour used. |
IP |
120mg q.s |
| 234 |
Flavoxate Tablet IP |
Each film coated tablet contains: Flavoxate
Excipients
Approved colour used |
IP |
200 mg q.s |
| 235 |
Fluconazole Tablet IP |
Each Uncoated Tablet Contains : - Fluconazole
Excipients
Colour : - Approved Colour used |
IP |
150mg q.s. |
| 236 |
Fluconazole Tablets IP |
Each uncoated tablet Contains: Fluconazole
Excipients
Approved colour used |
IP |
400mg q.s. |
| 237 |
FluconazoleTablets IP |
Each uncoated tablets contains: Fluconazole
Excipients
Approved colour used |
IP |
200 mg q.s. |
| 238 |
Flunarizine Tablets |
Each Uncoated Tablet Contains:
Flunarizine
(as Flunarizine Dihydrochloride) Excipients
Approved colour used |
BP |
5mg q.s. |
| 239 |
Flunarizine Tablets IP |
Each uncoated Tablet contains Flunarizine Hydrochloride Excipients
Approved Coloured used |
BP |
10mg q.s |
| 240 |
Fluoxetine & Alprazolam Tablets |
Each uncoated tablet contains: Fluoxetine Hydrochloride Eq. to fluoxetine
Alprazolam Excipients
Approved colour used |
IP IP |
20 mg
0.25 mg q.s |
| 241 |
FluoxetineTablet IP |
Each film coated tablet Contains :- Fluoxetine Hydrochloride
Equ. to Fluoxetine Excipients
Colour :- Approved colour used |
IP |
20mg q.s. |
| 242 |
Flupentixol Dihydrochloride & Melitracen Hydrochloride Tablets |
Each film coated tablet contains : Flupentixol Dihydrochloride Equ. To Flupentixol
Melitracen Hydrochloride Equ. To Melitracen Excipients
Approved colour used. |
BP |
0.5mg 10mg q.s |
| 243 |
Folic Acid Tablets IP |
Each uncoated Tablet Contains: Folic Acid
Excipients
Approved Colour used |
IP |
5mg q.s |
| 244 |
Folic Acid Tablets IP |
Each uncoated Tablet Contains: Folic Acid
Excipients
Approved Colour used |
IP |
10mg q.s |
| 245 |
Frusemide Tablets IP |
Each uncoated tablet contains: Frusemide
Excipients
Approved colour used. |
IP |
40mg q.s. |
| 246 |
Furosemide Tablets IP |
Each Uncoated Tablet Contains: Furosemide
Excipients |
IP |
40mg q.s. |
| 247 |
Gabapentin & Methylcobalamin Tablet |
Each film coated tablet contains; Gabapentin
Methylcobalamine Excipients
Approved colour used |
IP IP |
300mg 500mcg q.s |
| 248 |
Gabapentin & Methylcobalamin Tablets |
Each film coated Tablet Contains: Gabapentin
Methylcobalamin Excipients
Approved colour used. |
IP IP |
100mg 500mcg q.s. |
| 249 |
Gabapentin and Nortriptyline Tablets |
Each film coated Tablet contains: Gabapentin
Nortriptyline Hydrochloride Equ. To Nortriptyline Excipients
Approved colour used |
IP IP |
300mg
10mg q.s |
| 250 |
Gabapentin Tablet IP |
Each film coated tablet contains: Gabapentin
Excipients
Approved colour used |
IP |
100 mg q.s |
| 251 |
Gabapentin Tablet IP |
Each film coated tablet contains: Gabapentin
Excipients
Approved colour used |
IP |
400 mg q.s |
| 252 |
Gabapentin Tablet IP |
Each film coated tablet contains: Gabapentin
Excipients
Approved colour used |
IP |
800 mg q.s |
| 253 |
Gliclazide & Metformin Hydrochloride(SR)
Tablets |
Each Uncoated Bilayered Tablet Contains: Gliclazide
Metformin Hydrochloride (as Sustained Release) |
IP IP |
80mg 500mg q.s. |
| 254 |
Glimepiride & Metformin Hydrochloride (SR) Tablets |
Each uncoated Bilayered Tablet contains: Glimepiride
Metformin Hydrochloride (as Sustained Releaseform) Excipients
Approved colour used |
IP IP |
3mg 500mg
q.s. |
| 255 |
Glimepiride & Metformin Hydrochloride (SR) Tablets |
Each uncoated Bilayered Tablet contains: Glimepiride
Metformin Hydrochloride (as Sustained Releaseform) Excipients
Approved colour used |
IP IP |
4mg 1000mg
q.s. |
| 256 |
Glimepiride & Metformin Hydrochloride (Sustained Release) Tablets |
Each uncoated Bilayered Tablet contains: Glimepiride
Metformin Hydrochloride ( as Sustained Release) Excipients
Approved colour used. |
IP IP |
3mg 1000mg
q.s. |
| 257 |
Glimepiride and Metformin Hydrochloride (Sustained Release) Tablets IP |
Each uncoated Bilayered tablet contains: Glimepiride
Metformin Hydrochloride (as sustained release) Excipients
Approved colour used. |
IP IP |
1mg 1000mg
q.s. |
| 258 |
Glimepiride, Metformin Hydrochloride (ER) & Voglibose Tablets |
Each uncoated Bilayered Tablet Contains : Glimepiride
Metformin Hydrochloride (as Extended Release) Voglibose
Excipients
Approved colour used |
IP IP
IP |
1mg 500mg
0.3mg q.s. |
| 259 |
GlimepirideTablet IP |
Each uncoated tablet contains: Glimepiride
Excipients
Approved colour used |
IP |
1 mg q.s. |
| 260 |
GlimepirideTablet IP |
Each uncoated tablet contains: Glimepiride
Excipients
Approved colour used |
IP |
2 mg q.s. |
| 261 |
Griseofulvin Tablets IP |
Each uncoated Tablet Contains: Griseofulvin
Excipients
Approved Colour Used |
IP |
250mg q.s |
| 262 |
Griseofulvin Tablets IP |
Each Uncoated Tablet Contains: Griseofulvin
Excipients |
IP |
500mg q.s. |
| 263 |
Haloperidol Tablet IP |
Each Uncoated Tablet Contains: Haloperidol
Excipients |
IP |
5mg q.s. |
| 264 |
Hydoxychloroquine Tablets IP |
Each film coatedtablets contain: Hydroxychloroquine Sulphate Excipients |
IP |
200 mg q.s. |
| 265 |
Hydoxychloroquine Tablets IP |
Each film coatedtablets contain: Hydroxychloroquine Sulphate Excipients |
IP |
400 mg q.s. |
| 266 |
Hydrochlorothiazid e tablet IP |
Each film coated tablet contains:- Hydrochlorothiazide
Excipients
Colour : Approved Colour Used |
IP |
25mg q.s |
| 267 |
Hydrochlorothiazid e tablet IP |
Each film coated tablet contains:- Hydrochlorothiazide
Excipients
Colour : Approved Colour Used |
IP |
50mg q.s |
| 268 |
Hydroxyzine Hydrochloride Tablet |
Each uncoated tablet contains Hydroxyzine Hydrochloride eq. to Hydroxyzine Excipients
Colour :- Approved Colour Used |
IP |
10mg q.s. |
| 269 |
Hydroxyzine Hydrochloride Tablet |
Each uncoated tablet contains Hydroxyzine Hydrochloride eq. to Hydroxyzine Excipients
Colour :- Approved Colour Used |
IP |
25mg q.s. |
| 270 |
Hydroxyzine Hydrochloride Tablets IP |
Each Film Coated Tablet Contains: Hydroxyzine Hydrochloride Excipients
Approved colour used. |
IP |
25mg q.s. |
| 271 |
Hyoscine Butylbromide IP |
Each Film coated Tablet Contains : Hyoscine Butylbromide Excipients
Approved colour used. |
IP |
10mg q.s. |
| 272 |
Hyoscine Butylbromide Tablets IP |
Each Film coated Tablet Contains : Hyoscine Butylbromide Excipients
Colour: Approved colour used. |
IP |
10mg q.s. |
| 273 |
Ibuprofen & Paracetamol Tablets |
Each uncoated Tablet Contains Ibuprofen
Paracetamol Excipients
Approved Colour Used |
IP IP |
400mg 325mg q.s |
| 274 |
Ibuprofen Tablets IP |
Each film coated Tablet contains: Ibuprofen
Excipients
Approved colour used |
IP |
200mg |
| 275 |
Ibuprofen Tablets IP |
Each film coated Tablet contains: Ibuprofen
Excipients
Approved colour used |
IP |
400mg |
| 276 |
Isosorbide Dinitrate Tablets IP |
Each Uncoated Tablet Contains: Isosorbide Dinitrate
Excipients
Approved colour used |
IP |
5mg q.s. |
| 277 |
Isoxsuprine Tablets (Sustained Release) |
Each uncoated Sustained Release Tablet Contains Isoxsuprine Hydrochloride
Excipients
Approved colour used |
IP |
40mg q.s |
| 278 |
Ivermactin Tablet IP |
Each uncoated tablet contains: Ivermactin
Excipients
Approved colour used |
IP |
6 mg q.s |
| 279 |
Ivermactin Tablet IP |
Each uncoated tablet contains: Ivermactin
Excipients
Approved colour used |
IP |
12 mg q.s |
| 280 |
Ivermectin & Albendazole Tablets |
Each uncoated tablet contains: Ivermactin
Albendazole Excipients
Approved colour used |
IP IP |
12 mg 400mg q.s |
| 281 |
Ketoconazole Tablet IP |
Each uncoated tablet contain: Ketoconazole
Excipients
Approved colour used |
IP |
200 mg q.s |
| 282 |
Ketrolac Tromethamine DispersibleTablets |
Each uncoated dispersible tablets contains: Ketrolac Tromethamine
Excipients
Approved colour used |
IP |
10 mg q.s. |
| 283 |
L- Carnitine , L- Tartrate, Folic Acid & Methylcobalamin Tablets |
Each film coated Tablet contains: L-Carnitine L-Tartrate
Equ. To L-Carnitine Methylcobalamin Folic Acid Excipients
Approved colour used |
IP IP |
500mg 1500mcg 1.5mg q.s. |
| 284 |
L-Carnitine L- Tartrate, Methylcobalamin and Folic Acid Tablets |
Each Film Coated Tablet Contains: L-Carnitine L-Tartrate Methylcobalamin
Folic Acid Excipients
Approved colour used. |
IP IP |
500mg 1500mcg 1.5mg q.s. |
| 285 |
L-Mehtylfolate, Methylcobalamin & Pyridoxal-5-Phosphate Tablets |
Each film coated tablet contains: Calcium L-5 Methyltetrahydrofolate Equivalent to L-Methylfolate Methylcobalamin Pyridoxal-5-Phosphate Excipients Approved colour used Appropriate overages of vitamins added to compensate the possible loss on storage. |
U.S.P. I.P. |
5 mg 1500 mcg 0.5 mg q.s. |
| 286 |
L-methylfolate Calcium, Methylcobalamin, Pyridoxal-5-Phosphate Tablets |
Each film coated tablet contains:- L-methylfolate Methylcobalamin Pyridoxal-5-Phosphate Excipients Approved colour used . |
IP |
1mg 1500mcg 0.5mg q.s. |
| 287 |
Labetalol Tablets IP |
Each film coated Tablet Contains: Labetalol Hydrochloride Excipients
Approved colour used. |
IP |
50mg q.s |
| 288 |
Labetalol Tablets IP |
Each film coated Tablet Contains: Labetalol Hydrochloride Excipients
Approved colour used. |
IP |
100mg q.s |
| 289 |
Lactulose Solution USP |
Each 15ml contain: Lactulose
In flavoured Syrupybase Approved colour used |
USP |
10 gm. Q.s. |
| 290 |
Lansoprazole orally Disintegrating Tablets |
Each uncoated tablet contains:
Lansoprazole
(as enteric coated pellets) Excipients
Approved colour used |
IP |
15 mg q.s. |
| 291 |
Lansoprazole Orally Disintegrating Tablets 30mg |
Each uncoated orallyDisintegrating tablet contains:
Lansoprazole
(As enteric coated pellets ) Excipients
Approved colour used. |
IP |
30mg q.s. |
| 292 |
Leflunomide Tablet IP |
Each film coated Tablet Contains: Leflunomide
Excipients
Colour : Approved Coloured Used |
IP |
20mg q.s |
| 293 |
Leflunomide Tablet IP |
Each film coated Tablet Contains: Leflunomide
Excipients
Colour : Approved Coloured Used |
IP |
10mg q.s |
| 294 |
Letrozole Tablets USP |
Each film coated Tablet contains: Letrozole
Excipients
Approved colour used. |
USP |
2.5mg q.s. |
| 295 |
Levetiracetam Tablet IP |
Each film Coated Tablet Contains :- Levetiracetam
Excipients
Colour :- Approved colour used |
IP |
250mg q.s |
| 296 |
Levetiracetam Tablet IP |
Each film Coated Tablet Contains :- Levetiracetam
Excipients
Colour :- Approved colour used |
IP |
500mg q.s |
| 297 |
Levocetirizine Dihydrochloride & Montelukast DispersibleTablets |
Each uncoated dispersible Tablet contains : Levocetirizine Dihydrochloride Montelukast sodium
Equ. To
Montelukast Excipients |
IP IP |
2.5mg
4mg q.s |
| 298 |
Levocetirizine Dihydrochloride Tablets IP |
Each Uncoated Tablet Contains:- Levocetirizine Dihydrochloride Excipients
Colour :- Approved colour used |
IP |
5mg q.s. |
| 299 |
Levocetirizine Dihydrochloride Tablets IP |
Each film Coated Tablet Contains : Levocetirizine Dihydrochloride Excipients
Approved colour used. |
IP |
5mg q.s. |
| 300 |
Levocetirizine Hydrochloride Tablets IP |
Each Film coated Tablet Contains : Levocetirizine Hydrochloride Excipients
Approved colour Used. |
IP |
10mg q.s. |
| 301 |
Levodopa & Carbidopa Tablets IP |
Each Uncoated Tablet Contains: Carbidopa
Equ. To Carbidopa AnhydrousLevodopa Excipients
Approved colour used |
IP IP |
25mg 250mg q.s. |
| 302 |
Levofloxacin & OrnidazoleTablets |
Each film coated tablets contains: Levofloxacin hemihydrate Equivanent to Levofloxacin anhydrous Ornidazole
Excipients
Approved colour used |
IP IP |
250 mg
500 mg q.s. |
| 303 |
Levofloxacin Tablets IP |
Each film coated tablet contains:- Levofloxacin Hemihydrate Equivalent to Levofloxacin Excipients
Colour:- Approved colour used |
IP |
250 mg. q.s. |
| 304 |
Levofloxacin Tablets IP |
Each film coated tablet contains:- Levofloxacin Hemihydrate Equivalent to Levofloxacin Excipients
Colour:- Approved colour used |
IP |
500 mg. q.s. |
| 305 |
Levofloxacin Tablets IP |
Each film coated tablet contains:- Levofloxacin Hemihydrate Equivalent to Levofloxacin Excipients
Colour:- Approved colour used |
IP |
750 mg. q.s. |
| 306 |
Levosulpiride Tablets |
Each Uncoated Tablet Contains: Levosulpiride
Excipients |
|
25mg q.s. |
| 307 |
Levothyroxine sodium Tablets USP |
Each uncoated Tablet Contains: Levothyroxine Sodium
Equ. To Anhydrous Levothyroxine SodiumExcipients |
USP |
50mcg q.s. |
| 308 |
Linezolid Tablet IP |
Each film coated tablet contains:- Linezolid
Excipients
Colour:- Approved colour used |
IP |
600 mg q.s. |
| 309 |
Lithium Carbonate Prolonged ?Release Tablets IP |
Each uncoated Prolonged-Release tablet contains: Lithium Carbonate
Excipients
Approved colour used. |
IP |
450mg q.s. |
| 310 |
Loperamide Hydrochloride Tablets IP |
Each uncoated tablet contains:- Loperamide Hydrochloride Excipients
Colour : Approved Coloured Used |
IP |
2 mg q.s. |
| 311 |
Loratadine Tablet USP |
Each uncoated table contains:- Loratadine
Excipients
Approved colour used |
USP |
10 mg q.s. |
| 312 |
Lornoxicam & Paracetamol Tablets |
Each film coated Tablet Contains :- Lornoxicam
Paracetamol Excipients
Colour :- Approved colour used |
IP IP |
4mg 325mg q.s. |
| 313 |
Lornoxicam & Paracetamol Tablets |
Each film coated Tablet Contains :- Lornoxicam
Paracetamol Excipients
Colour :- Approved colour used |
IP IP |
8mg 325mg q.s. |
| 314 |
Losartan Potassium & Amlodipine Besilate Tablet IP |
Each film coated tablet contains: Losartan Potassium Amlodipine Besilate
Eq. to Amlodipine Excipients
Approved colour used |
IP IP |
50 mg
5 mg q.s. |
| 315 |
Losartan Potassium & Hydrochlorothiazid e
Tablet IP |
Each film coated tablet contains: Losartan Potassium Hydrochlorothiazide Excipients
Approved colour used |
IP IP |
50 mg
12.5 mg q.s. |
| 316 |
Losartan Potassium Tablet IP |
Each film coated tablet contains: Losartan Potassium
Excipients
Approved colour used |
IP |
50 mg |
| 317 |
Losartan potassium Tablets IP |
Each film coated tablet contains:
Losartan potassium
Excipients
Approved colour used. |
IP |
25mg q.s. |
| 318 |
Mecobalamin Tablets |
Each film coated Tablet contains: Mecobalamin
Excipients
Approved colour used. |
IP |
1500mcg q.s. |
| 319 |
Mecobalamin, Alpha Lipoic Acid, Benfotiamine,
Folic acid,Chromium Picolinate,Inositol, Pyridoxine HCL, Vitamin D3, & Calcium Carbonate Tablets |
Each film coated tablet contains: Mecobalamin
Alpha Lipoic Acid Benfotiamine Folic acid
Chromium Picolinate Inositol,
Pyridoxine HCL Vitamin D3 Calcium Carbonate Excipients
Approved colour used. |
IP IP
IP IP IP IP IP IP |
1500 mcg
100 mg
150 mg
1.5 mg
200 mcg
100 mg
3 mg
1000 IU
500mg q.s. |
| 320 |
Mefenamic Acid & Dicyclomine HCl Tablets |
Each uncoated Tablet contains: Mefenamic Acid
Dicyclomine HCl
Excipients |
IP IP |
250mg 20mg q.s |
| 321 |
Mefenamic Acid & Dicyclomine Tablets IP |
Each uncoated tablet contains:- Mefenamic Acid
Dicyclomine Hydrochloride Excipients
Colour:- Approved Colour used |
IP IP |
250 mg
10 mg q.s. |
| 322 |
Mefenamic Acid & Paracetamol Tablet |
Each uncoated tablet contain: Mefenamic Acid Paracetamol
Excipients
Approved colour used |
IP IP |
500 mg
325 mg q.s. |
| 323 |
Mefenamic Acid & Paracetamol Tablets |
Each uncoated tablet contains: Mefenamic Acid
Paracetamol Excipients
Approved Colour used |
IP IP |
250mg 325mg q.s. |
| 324 |
Memantine Hydrochloride & Donepezil Hydrochloride Tablets |
Each film coated tablet contains:
Memantine Hydrochloride Donepezil Hydrochloride Excipients
Approved colour used. |
IP IP |
5mg 5mg q.s. |
| 325 |
Metformin Hydrochloride (Prolong Release) and Glimepiride Tablet IP |
Each uncoated bilayer tablet contains:-
Metformin Hydrochloride (Prolonged Release) Glimepiride
Excipients
Colour:- Approved Colour Used |
IP IP |
500 mg
1 mg q.s. |
| 326 |
Metformin Hydrochloride (Prolong Release) and Glimepiride Tablet IP |
Each uncoated bilayer tablet contains:-
Metformin Hydrochloride (Prolonged Release) Glimepiride
Excipients
Colour:- Approved Colour Used |
IP IP |
500 mg
2 mg q.s. |
| 327 |
Metformin Hydrochloride (SR) & Glimepiride Tablets IP |
Each Uncoated Bilayered Tablet Contains: Glimepiride
Metformin Hydrochloride (as Sustained Release) Excipients
Approved colour used. |
IP IP |
2mg 500mg
q.s. |
| 328 |
Metformin Hydrochloride (Sustained Release)
, Gliclazide (Sustained Release) & Pioglitazone Tablets |
Each uncoated Bilayered Tablet Contains:
Metformin Hydrochloride (as Sustained Release)
Gliclazide
(as Sustained Release) Pioglitazone Hydrochloride Equ. To Pioglitazone Excipients
Approved colour used. |
IP IP IP |
500mg 30mg
15mg q.s. |
| 329 |
Metformin Hydrochloride (Sustained Release) & Glimepiride Tablets IP |
Each Uncoated Bilayered Tablet Contains: Glimepiride
Metformin Hydrochloride (as Sustained Release) Excipients
Approved colour used. |
IP IP |
1mg 500mg
q.s. |
| 330 |
Metformin Hydrochloride & GliclazideTablets |
Each uncoated tablets contains: Metformin hydrochloride Gliclazide
Excipients
Approved colour used |
IP IP |
500 mg
80 mg |
| 331 |
Metformin Hydrochloride Prolonged Release & Glimepiride Tablets IP |
Each uncoated Bilayered tablet contains:
Metformin Hydrochloride (as Prolonged Release) Glimepiride
Excipients
Approved colour used |
IP IP |
1000mg
2mg q.s |
| 332 |
Metformin Hydrochloride Sustained-Release
Tablets |
Each uncoated Sustained Release Tablet Contains : Metformin Hydrochloride
Excipients |
IP |
500mg q.s. |
| 333 |
Metformin Hydrochloride Sustained-Release Tablets |
Each uncoated Sustained Release Tablet Contains : Metformin Hydrochloride
Excipients |
IP |
850mg q.s. |
| 334 |
Metformin Hydrochloride Sustained-Release Tablets |
Each uncoated Sustained Release Tablet Contains : Metformin Hydrochloride
Excipients |
IP |
1000mg q.s. |
| 335 |
Metformin Hydrochloride Tablets IP |
Each uncoated sustainedrelease tablet contains: Metformin Hydrochloride
Excipients
Approved colour used |
IP |
500 mg q.s. |
| 336 |
Metformin hydrochloride,(ER) Pioglitazone and GlimepirideTablets |
Each uncoated Bilayered tablets contain:
Metformin hydrochloride (as Extended release) Pioglitazone Hydrochloride Eq.to Pioglitazone Glimepiride
Excipients |
IP IP IP |
500 mg
15 mg
2 mg q.s |
| 337 |
Metformin hydrochloride,(ER) Pioglitazone and Glimipride Tablets |
Each uncoated Bilayered tablets contain:
Metformin hydrochloride (as Extended release) Pioglitazone Hydrochloride. Eq.to Pioglitazone Glimepiride
Excipients
Approved colour used |
IP IP IP |
500 mg
15 mg
1 mg q.s |
| 338 |
Methotrexate Tablets IP |
Each uncoated tablet contains:
Methotrexate Excipients
Approved colour used. |
IP |
2.5mg q.s. |
| 339 |
Methylcobalamin Sublingual Tablets |
Each uncoated sublingual tablet contains : Methylcobalamin
Excipients |
IP |
1500mcg q.s. |
| 340 |
Methylcobalamin Tablets |
Each film coated Tablet Contains: Methylcobalamin
Excipients
Approved colour used. |
|
1500mcg q.s. |
| 341 |
Methylcobalamin, Alpha Lipoic Acid, Pyridoxine Hydrochloride, Thiamine Mononitrate & Folic Acid Tablets |
Each film coated tablet contains: Methylcobalamin Alpha Lipoic Acid Pyridoxine Hydrochloride Thiamine Mononitrate Folic Acid Excipients Approved colour used. |
IP USP IP IP IP |
1500mcg 100mg 3mg 10mg 1.5mg q.s. |
| 342 |
Methylcobalamin, Alpha Lipoic Acid, Pyridoxine Hydrochloride,Thiamine Mononitrate & Folic Acid Tablets |
Each film coated tablet contains: Methylcobalamin
Alpha Lipoic Acid Pyridoxine Hydrochloride Thiamine Mononitrate Folic Acid
Excipients
Approved colour used. |
IP USP IP IP IP |
1500mcg 100mg 3mg 10mg 1.5mg q.s. |
| 343 |
Methylcobalamin, Calcium Citrate, Calcitriol, Folic Acid & Pyridoxine Hydrochloride Tablets |
Each film coated Tablet Contains: Methylcobalamin
Calcium Citrate Calcitriol
Folic Acid
Pyridoxine Hydrochloride Excipients
Approved colour used |
IP USP IP IP IP |
1500mcg 750mg 0.25mcg 1.5mg 3mg
q.s. |
| 344 |
Methylcobalamin, L-Methylfolate & Pyridoxine HCl Tablets |
Each film coated Tablet Contains : Methylcobalamin
L-Methylfolate Pyridoxine HCl Excipients
Approved Colour Used |
IP IP |
1500mcg 1MG
0.5mg q.s |
| 345 |
Methylcobalamin, L-Methylfolate, PyridoxalPhosphate, Vitamin D3 & Docosahexaenoic Acid (DHA) Tablets |
Each film coated tablet contains:Methylcobalamin L-Methylfolate Pyridoxal Phosphate Vitamin D3 Docosahexaenoic Acid (DHA) Excipients Approved colour used. Appropriate overages of vitamins added to compensate the loss on storage. |
I.P. I.P. I.P. I.P. |
1500 mcg 1.0 mg 0.5 mg 1000 IU 100 mg q.s. |
| 346 |
Methylcobalamine, Alpha Lipoic Acid Vitamin D3,Pyridoxine Hydrochloride
,Folic Acid Tablets |
Each film coated Tablet Contains: Methylcobalamine
Alpha LipoicAcid Vitamin D3
Pyridoxine Hydrochloride Folic Acid
Excipients
Approved Colour Used. |
IP USP IP IP IP |
1500mcg 100mg 1000IU
3mg 1.5mg q.s. |
| 347 |
Methylprednisolone Tablets |
Each uncoated tablet contains:- Methylprednisolone Excipients
Colour :- Approved Colour Used |
IP |
8 mg q.s. |
| 348 |
Methylprednisolone Tablets IP |
Each uncoated tablet contains:- Methylprednisolone Excipients
Colour :- Approved Colour Used |
IP |
4 mg q.s. |
| 349 |
Methylprednisolone Tablets IP |
Each uncoated tablet contains:- Methylprednisolone Excipients
Colour :- Approved Colour Used |
IP |
2 mg q.s. |
| 350 |
Methylprednisolone Tablets IP |
Each uncoated tablet contains:- Methylprednisolone Excipients
Colour :- Approved Colour Used |
IP |
16 mg q.s. |
| 351 |
Methylprednisolone Tablets IP |
Each uncoated tablet contains:- Methylprednisolone Excipients
Colour :- Approved Colour Used |
IP |
16 mg q.s. |
| 352 |
Metoprolol Succinate (ER) & Hydrochlorothiazid e Tablets |
Each uncoated Bilayered tablet contains: Metoprolol Succinate
Eq. to Metoprolol Tartrate (As Extended Release) Hydrochlorothiazide Excipients
Approved colour used |
IP
IP |
47.5 mg
50 mg
12.5 mg q.s. |
| 353 |
Metoprolol Succinate (ER) & Hydrochlorothiazid e Tablets |
Each uncoated Bilayered tablet contains: Metoprolol Succinate
Eq. to Metoprolol Tartrate (As Extended Release) Hydrochlorothiazide Excipients
Approved colour used |
IP
IP |
23.75 mg
25 mg
12.5 mg q.s. |
| 354 |
Metoprolol Succinate (ER) Tablets IP |
Each film coated tablet contains: Metoprolol Succinate Eq. to Metoprolol Tartrate (As Extended Release Excipients"Approved colour used |
IP |
47.5 mg
50 mg
q.s. |
| 355 |
Metoprolol Succinate Prolonged release Tablets IP |
Each film coated Prolonged release Tablet Contains Metoprolol succinate
Equ. to Metoprolol Tartrate Excipients
Colour :- Approved colour used |
IP |
23.75mg
25mg q.s. |
| 356 |
Metoprolol Succinate(ER) & Amlodipine Besilate Tablets |
Each film coated Bilayered tablet contains: Metoprolol Succinate
Eq. to Metoprolol Tartrate (As Extended Release) Amlodipine Besilate
Eq. to Amlodipine Excipients
Approved colour used |
IP
IP |
47.5 mg
50 mg
5 mg q.s. |
| 357 |
Metoprolol Succinate(ER) & Amlodipine Besilate Tablets |
Each film coated Bilayered tablet contains: Metoprolol Succinate
Eq. to Metoprolol Tartrate (As Extended Release) Amlodipine Besilate
Eq. to Amlodipine Excipients
Approved colour used |
IP
IP |
23.75 mg
25 mg
5 mg q.s. |
| 358 |
Metoprolol SuccinateExtended release
Tablets IP |
Each film coated Extended release Tablet Contains Metoprolol succinate
Equ. To Metoprolol TartrateExcipients
Colour :- Approved colour used |
IP |
11.875mg
12.5mg q.s. |
| 359 |
Metronidazole Oral solution |
Each 5ml contains : Metronidazole Benzoate Equ. To Metronidazole
In a flavoured Syrupy Base. Colour : Approved Coloured Used |
IP |
250mg q.s |
| 360 |
Metronidazole Tablet IP |
Each film coated Tablet Contains: Metronidazole
Excipients
Colour : Approved Coloured Used |
IP |
200mg q.s |
| 361 |
Metronidazole Tablet IP |
Each film coated Tablet Contains: Metronidazole
Excipients
Colour : Approved Coloured Used |
IP |
400mg q.s |
| 362 |
Minocycline Hydrochloride Tablet |
Each film coated Tablet Contains Minocycline Hydrochloride Equ. To Minocycline
Excipients
Colour : Approved Coloured Used |
USP |
100mg q.s |
| 363 |
Minoxidil Tablets IP |
Each Uncoated Tablet Contains: Minoxidil
Excipients |
IP |
5mg q.s. |
| 364 |
Minoxidil Tablets IP |
Each uncoated tablet Contains: Minoxidil
Excipients
Approved colour used |
IP |
2.5mg q.s. |
| 365 |
Minoxidil Topical solution USP |
Each ml contains: Minoxidil Excipients
Approved colour used |
IP |
20mg q.s |
| 366 |
Mometasone Furoate & Terbinafine Hydrochloride
Cream |
Composition:- Mometasone Furoate Terbinafine Hydrochloride Cream Base |
IP IP |
0.1% w/w
1% w/w q.s. |
| 367 |
Montelukast & Doxophylline (SR) Tablets |
Each uncoated tablet contains:- Montelukast Sodium Equivalent to Montelukast Doxophylline
(As Sustained Release) Excipients
Colour:- Approved colour used |
IP IP |
10 mg
400 mg q.s |
| 368 |
Montelukast & Levocetirizine HCL Dispersible Tablets |
Each uncoated dispersible tablet contains: Montelukast sodium
Eq.to Montelukast Levocetirizine HCL Excipients
Approved colour used. |
IP IP |
4 mg
2.5 mg |
| 369 |
Montelukast & Levocetirizine HCl Tablets |
Each uncoated Bilayered Tablet Contains : Montelukast Sodium
Equ. To Montelukast Levocetirizine Hydrochloride Excipients
Approved colour used. |
IP IP |
10mg 5mg q.s. |
| 370 |
Montelukast Sodium
& Levocetirizine Dihydrochloride Tablets IP |
Each Uncoated Tablet Contains:-
Montelukast Sodium eq. to Montelukast
LevocetirizineDihydrochloride Excipients
Approved colour used |
IP IP |
4mg 2.5mg q.s. |
| 371 |
Montelukast Sodium
& Levocetirizine Dihydrochloride Tablets IP |
Each film coated Tablet Contains:-
Montelukast Sodium eq. to Montelukast
LevocetirizineDihydrochloride Excipients
Approved colour used |
IP IP |
10 mg 5mg q.s. |
| 372 |
Montelukast sodium & Bambuterol Hydrochloride Tablets |
Each film coated Tablet contains: Montelukast sodium
Equ. To Montelukast Bambuterol Hydrochloride Excipients
Approved colour used |
IP BP |
10mg 10mg q.s. |
| 373 |
Montelukast Sodium & Desloratadine Tablet |
Each film coated Tablet Contains:- Montelukast Sodium
Equivalent to Montelukast Desloratadine
Excipients
Approved colour used |
IP BP |
10 mg
5 mg q.s |
| 374 |
Montelukast Sodium & Levocetirizine Dihydrochloride DispersibleTablets |
Each Uncoated Dispersible Tablet Contains : Montelukast Sodium
Equ. To Montelukast LevocetirizineDihydrochloride Excipients
Colour : Approved Coloured used |
IP IP |
5mg 2.5mg q.s. |
| 375 |
Montelukast Sodium & Levocetirizine Dihydrochloride Tablets IP |
Each uncoated Tablet contains: Montelukast sodium
Equ. To Montelukast LevocetirizineDihydrochloride Excipients
Approved colour used. |
IP IP |
10mg 5mg q.s. |
| 376 |
Montelukast Sodium Chewable Tablets |
Each Uncoated Chewable Tablet Contains : Montelukast sodium
Equ. To Montelukast
Excipients |
IP |
4mg q.s. |
| 377 |
Montelukast Sodium, Fexofenadine Hydrochloride and Sustained Release Acebrophylline Tablets |
Each film coated Tablet contains: Montelukast sodium
Equ. To Montelukast Fexofenadine Hydrochloride Acebrophylline
(As sustainedrelease form) Excipients
Approved colour used |
IP IP |
10mg 120mg 200mg
q.s |
| 378 |
Montelukast sodium, Levoceterizine dihydrochloride & Ambroxol hydrochloride Tablets |
Each film coated tablets contains: Montelukast sodium
Equivalent to Montelukast Levoceterizine dihydrochloride Ambroxol hydrochloride
(As sustainedrelease) Excipients
Approved colour used |
IP
IP IP |
10 mg
5 mg
75 mg q.s. |
| 379 |
Montelukast SodiumTablets IP |
Each Film coated Tablet Contains : Montelukast Sodium
Equ. To Montelukast Excipients
Approved colour used |
IP |
10mg q.s. |
| 380 |
Moxifloxacin Hydrochloride Tablets |
Each Film coated Tablet Contains : Moxifloxacin Hydrochloride
Equ. To Moxifloxacin Excipients
Approved colour used. |
IP |
400mg q.s. |
| 381 |
Moxonidine Tablets |
Each film coated tablet contains:
Moxonidine Excipients
Approved colour used |
BP |
0.2mg q.s. |
| 382 |
Moxonidine Tablets |
Each film coated tablet contains:
Moxonidine Excipients
Approved colour used |
BP |
0.3mg q.s. |
| 383 |
Naproxen & Domperidone Tablets |
Each film coated tablet contains: Naproxen
Domperidone Excipients
Approved colour used |
IP IP |
500mg 10mg q.s |
| 384 |
Naproxen & Domperidone Tablets |
Each Film coatedtablet contains: Naproxen Domperidone Excipients Approved colour used. |
IP IP |
250 mg
10 mg q.s |
| 385 |
Naproxen Sodium & Domperidone Tablet |
Each uncoated tablet contain: Naproxen Sodium Domperidone
Excipients
Approved colour used |
IP IP |
250 mg
10 mg q.s |
| 386 |
Naproxen Sustained Release Tablets IP |
Each uncoated sustained release tablet contains: Naproxen
Excipients
Approved colour used |
IP |
750mg q.s. |
| 387 |
Naproxen Tablet IP |
Each uncoated tablet contain: Naproxen
Excipients
Approved colour used |
IP |
250 mg q.s |
| 388 |
Naproxen Tablet IP |
Each uncoated tablet contain: Naproxen
Excipients
Approved colour used |
IP |
500 mg q.s |
| 389 |
Nebivolol & Hydrochlorothiazid e Tablets |
Each uncoated Tablets Contains: Nebivolol Hydrochloride
Equ. To Nebivolol Hydrochlorothiazide Excipients
Approved colour used. |
IP IP |
5mg 12.5mg q.s. |
| 390 |
Nebivolol Hydrochloride Tablets IP |
Each uncoated tablet contains: Nebivolol Hydrochloride Eq. to Nebivolol Excipients Approved colour used. |
IP |
5mg q.s. |
| 391 |
Nicorandil Tablets IP |
Each uncoated Tablets Contains: Nicorandil
Excipients |
IP |
5mg |
| 392 |
Nicorandil Tablets IP |
Each uncoated Tablets Contains: Nicorandil
Excipients |
IP |
10mg |
| 393 |
Nifedipine Prolonged Release Tablets BP |
Each Prolonged Release film coated tablet contains: Nifedipine
Excipients
Approved colour used. |
BP |
30mg q.s. |
| 394 |
Nimesulide & Paracetamol Tablets |
Each uncoated tablet contains: Nimesulide
Paracetamol Excipients |
BP IP |
100 mg
325 mg q.s. |
| 395 |
Nimesulide & Paracetamol Tablets |
Each uncoated Bilayered Tablet contains: Nimesulide
Paracetamol Excipients
Approved colour used. |
BP IP |
100mg 325mg q.s. |
| 396 |
Nimesulide Mouth Dissolving Tablets |
Each uncoated Mouth dissolving Tablet contains : Nimesulide
Excipients
Approved colour used. |
BP |
100mg q.s. |
| 397 |
Nimesulide Tablets |
Each uncoated tablet contains:- Nimesulide
Excipients
Colour:- Approved colour used |
BP |
100 mg q.s. |
| 398 |
Nimesulide, Paracetamol & Chlorzoxazone Tablets |
Each film coated tablet contains: Nimesulide
Paracetamol Chlorzoxazone Excipients
Approved colour used |
BP IP USP |
100mg 325mg 250mg q.s |
| 399 |
Nimesulide, Paracetamol, Phenylephrine HCl & Caffeine Tablets |
Each uncoated Tablet Contains: Nimesulide
Paracetamol
Phenylephrine Hydrochloride Caffeine (anhydrous) Excipients |
BP IP IP IP |
100mg 325mg 10mg 25mg q.s. |
| 400 |
Nimesulide, Paracetamol, Serratiopeptidase Tablets |
Each film coated tablet contains :
Nimesulide Paracetamol Serratiopeptidase
((Eq. to enzyme activityof 30000 units of enteric coated granules)
Excipients
Approved colour used. |
BP IP IP |
100mg 325mg 15mg |
| 401 |
Nimesulide, Phenylephrine HCL, Cetirizine Dihydrochloride & Caffeine Tablets |
Each uncoated tablet contains:- Nimesulide Phenylephrine Hydrochloride Cetirizine Dihydrochloride Caffeine (anhydrous) Excipients Colour:-Approved colour used |
BP IP IP IP |
100 mg
10 mg
5 mg
30 mg q.s. |
| 402 |
Nimesulide, Phenylephrine HCl& Levocetirizine HCl Tablets |
Each uncoated tablet contains: Nimesulide
Phenylephrine HCl Levocetirizine HCl Excipients
Approved Colour used |
BP IP IP |
100mg 5mg 5mg q.s. |
| 403 |
Nimesulide, Phenylephrine Hydrochloride, Cetirizine Dihydrochloride & Caffeine Tablets |
Each film Coated Tablet Contains : Nimesulide
Phenylephrine Hydrochloride Cetirizine Dihydrochloride Caffeine ( Anhydrous) Excipients
Approved colour Used. |
BP IP IP IP |
100mg 10mg 5mg 30mg q.s. |
| 404 |
Nimodipine Tablets |
Each Film coated Tablet Contains : Nimodipine
Excipients
Approved colour used. |
IP |
30mg q.s. |
| 405 |
Nitrofurantoin SR Tablet |
Each Film Coated Sustained Release Tablet Contains Nitrofurantoin
Excipients
Colour :- Approved colour used |
BP |
100mg q.s. |
| 406 |
Nitroglycerine Controlled Release Tablet |
Each uncoated Tablet contains: Diluted Nitroglycerine
Equ. To Nitroglycerin (as Controlled Release) Excipients
Approved colour used |
IP |
2.6mg q.s. |
| 407 |
Norfloxacin & TinidazoleTablets |
Each film coated tablet contains:- Norfloxacin
Tinidazole Excipients
Colour:- Approved colour used |
IP IP |
400 mg
600 mg q.s. |
| 408 |
Norfloxacin Tablets IP |
Each film coated Tablet Contains: Norfloxacin
Excipients
Approved Colour Used |
IP |
400mg q.s |
| 409 |
Nortriptyline & Gabapentin Tablets |
Each Film coated Tablet Contains:- Nortriptyline Hydrochloride Equivalent to Nortriptyline Gabapentin
Excipients
Approved colour used |
IP IP |
10 mg
400 mg q.s. |
| 410 |
Nortriptyline & PregabalineTablets |
Each film coated Tablet Contains: Nortriptyline Hydrochloride Equivalent to Nortriptyline Pregabaline
Excipients
Approved colour used |
IP IP |
10 mg
75 mg q.s. |
| 411 |
Nortriptyline, Pregabalin (SR) & Methylcobalamin Tablets |
Each film coated Bilayered Tablet Contains: Nortriptyline Hydrochloride
Equivalent to Nortriptyline Pregabalin
(as Sustained Release) Methylcobalamin Excipient
Approved colour used |
IP IP IP |
10 mg
75 mg
1500mcg q.s. |
| 412 |
Nortriptyline, Pregabalin & Mecobalamin Tablets |
Each film coated Tablet Contains: Nortriptyline Hydrochloride Equivalent to Nortriptyline Pregabalin
Mecobalamin Excipient
Approved colour used |
IP
IP IP |
10 mg
75 mg 1500mcg q.s. |
| 413 |
Nortriptyline, Pregabalin & Methylcobalamin Tablets |
Each film coated Bilayered Tablet Contains: Nortriptyline Hydrochloride
Equivalent to Nortriptyline Pregabalin Methylcobalamin Excipient
Approved colour used |
IP
IP IP |
10 mg
75 mg 1500mcg q.s. |
| 414 |
Ofloxacin & Lactic Acid Bacillus Tablets |
Each Film coated Tablet Contains : Ofloxacin
Lactic Acid Bacillus Excipients
Approved colour used. |
IP |
200mg 60 Million Spores q.s. |
| 415 |
Ofloxacin & Ornidazole Tablet IP |
Each Film Coated Tablet Contains: Ofloxacin
Ornidazole Excipients
Approved colour used |
IP IP
q.s. |
200 mg
500 mg |
| 416 |
Ofloxacin & TinidazoleTablets |
Each film coated tablet contains: Ofloxacin
Tinidazole Excipients
Approved colour used. |
IP IP |
200mg 600mg q.s. |
| 417 |
Ofloxacin Tablet IP |
Each film coated tablet contains:- Ofloxacin
Excipients
Approved colour used |
IP |
400 mg q.s. |
| 418 |
Ofloxacin Tablets IP |
Each Film Coated Tablet Contains: Paracetamol
Tramadol Hydrochloride Excipients
Approved Colour Used |
IP IP |
325mg 37.5mg q.s. |
| 419 |
OlanzapineTablet IP |
Each film coated tablet contains: Olanzapine
Excipients
Approved colour used |
IP |
5mg q.s. |
| 420 |
OlanzapineTablet IP |
Each film coated tablet contains: Olanzapine
Excipients
Approved colour used |
IP |
2.5mg q.s. |
| 421 |
OlanzapineTablet IP |
Each film coated tablet contains: Olanzapine
Excipients
Approved colour used |
IP |
7.5 mg q.s. |
| 422 |
OlanzapineTablets IP |
Each film coated tablet contains: Olanzapine
Excipients
Approved colour used |
IP |
10 mg q.s. |
| 423 |
Olmesartan & AmlodipineTablets |
Each film coated tablet contains: Olmesartan Medoxomil Amlodipine Besilate
Eq. to Amlodipine Excipients
Approved colour used |
IP IP |
20 mg
5 mg q.s |
| 424 |
Olmesartan & Chlorthalidone Tablets |
Each film coated tablet contains: Olmesartan Medoxomil Chlorthalidone
Excipients
Approved colour used |
IP IP |
20 mg
12.5 mg
q.s |
| 425 |
Olmesartan & Hydrochlorothiazid e Tablets |
Each film coated tablet contains: Olmesartan Medoxomil Hydrochlorothiazide Excipients
Approved colour used |
IP IP |
20 mg
12.5 mg
q.s |
| 426 |
Olmesartan & Metoprolol SuccinateTablets |
Each film coated Bilayered tablet contains: Olmesartan Medoxomil
Metoprolol Succinate
Eq. to Metoprolol Tartrate (As Extended Release) Excipients
Approved colour used |
IP IP |
20 mg
47.5 mg
50 mg q.s |
| 427 |
Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazid e Tablets |
Each film coated Tablet Contains: Olmesartan Medoxomil Amlodipine Besylate
Equ. To Amlodipine Hydrochlorothiazide Excipients
Approved Colour used. |
IP IP
IP |
40mg
5mg 12.5mg q.s. |
| 428 |
Olmesartan, Amlodipine & Hydrochlorothiazid e Tablets |
Each film coated tablet contains: Olmesartan Medoxomil Amlodipine Besilate
Eq. to Amlodipine Hydrochlorothiazide Excipients
Approved colour used |
IP IP
IP |
20 mg
5 mg
12.5 mg q.s |
| 429 |
Olmesarton Medoxomil & Hydrochlorthiazide Tablet |
Each film coated tablet contains: Olmesarton Medoxomil Hydrochlorthiazide
Excipients
Approved colour used |
IP IP |
40 mg
12.5 mg q.s. |
| 430 |
Olmesarton Medoxomil Tablet IP |
Each film coated tablet contains: Olmesarton Medoxomil Excipients
Approved colour used |
IP |
20 mg q.s. |
| 431 |
Olmesarton Medoxomil Tablet IP |
Each film coated tablet contains: Olmesarton Medoxomil Excipients
Approved colour used |
IP |
40 mg q.s. |
| 432 |
Ondansetron Oral Solution IP |
Each 5 ml contains: Ondansetron Hydrochloride Equ. To Ondansetron Flavoured Syrupy Base |
IP |
4mg q.s. |
| 433 |
Ondansetron Orally Disintegrating TabletsTablet IP |
Each Uncoated OrallyDisintegrating Tablets Contains Ondansetron hydrochloride
Equ. toOndansetron Excipients
Approved colour used. |
IP |
4mg |
| 434 |
Ondansetron Orally Disintegrating TabletsTablet IP |
Each Uncoated OrallyDisintegrating Tablets Contains Ondansetron hydrochloride
Equ. toOndansetron Excipients
Approved colour used. |
IP |
8mg |
| 435 |
Ornidazole , Diloxanide & Simethicone Tablets |
Each film coated tablet contains:
Ornidazole Diloxanide furoate Simethicone Excipients
Approved colour used. |
IP IP IP |
250mg 375mg 25mg q.s. |
| 436 |
Ornidazole Tablets |
Each Film coated Tablet Contains : Ornidazole
Excipients
Approved colour used. |
IP |
500mg q.s. |
| 437 |
Pancreatin, Simethicone & Activated Charcoal Tablets |
Each film coated Tablet Contains: Pancreatin
Simethicone Activated Charcoal Excipients
Approved colour used |
IP IP IP |
175mg 50mg 50mg q.s. |
| 438 |
Pantoprazole Gastro-resistant and Domperidone Prolonged ?elease
Capsules IP |
Each hard gelatin capsule contains:- Pantoprazole Sodium Sesquihydrate Equivalent to Pantoprazole (As Enteric Coated Pellets) Domperidone "(As Prolonged Release Pellets) Excipients Approved colour used in emptycapsule shells." |
IP
IP |
40 mg
30 mg |
| 439 |
Pantoprazole Gastro-Resistant Tablets IP |
Each enteric coated tablet contains:- Pantoprazole Sodium
Eq. to Pantoprazole Excipients
Colour:- Approved colour used |
IP |
40 mg q.s. |
| 440 |
Pantoprazole Sodium & Domperidone Tablets |
Each enteric coated tablet contains:- Pantoprazole Sodium
Eq. to Pantoprazole Domperidone Excipients
Colour:- Approved colour used |
IP IP |
40 mg
10 mg q.s. |
| 441 |
Pantoprazole Tablets IP |
Each enteric coated Tablet contains : Pantoprazole sodium sesquihydrate Equ. To Pantoprazole
Excipients
Approved colour used. |
IP |
20mg q.s. |
| 442 |
Paracetamol (DT) Tablets BP |
Each uncoated dispersible tablet contains: Paracetamol
Excipients
Approved colour used. |
IP |
650 mg q.s. |
| 443 |
Paracetamol & Diclofenac Tablets IP |
Each uncoated tablet contains:- Paracetamol
Diclofenac Sodium Excipients
Colour:- Approved colour used |
IP IP |
325 mg
50 mg q.s. |
| 444 |
Paracetamol & Dicyclomine Hydrochloride
Tablets |
Each uncoated Tablet contains: Paracetamol
Dicyclomine Hydrochloride
Excipients |
IP IP |
325mg 20mg q.s. |
| 445 |
Paracetamol & Domperidone Tablets |
Each uncoatedtablet contains : Paracetamol
Domperidone Excipients
Approved colour used. |
IP IP |
325mg 10mg q.s. |
| 446 |
Paracetamol and CaffeineTablets IP |
Each uncoated Tablet contains: Paracetamol
Caffeine Excipients |
IP IP |
650mg 50mg q.s. |
| 447 |
Paracetamol and CaffeineTablets IP |
Each Film Coated Tablet contains: Paracetamol
Caffeine Excipients
Approved Colour used. |
IP IP |
650mg 50mg q.s. |
| 448 |
Paracetamol Bilayered Sustained Release Tablets |
Each uncoated Bilayered Sustained Release Tablet contains : Paracetamol (As Immediate Release)
Paracetamol (As Sustained Release) Excipients
Approved Colour used. |
IP IP |
300mg 700mg q.s. |
| 449 |
Paracetamol Tablets IP |
Each uncoated tablet contains:- Paracetamol
Excipients
Colour:- Approved colour used |
IP |
650 mg q.s. |
| 450 |
Paracetamol Tablets IP |
Each uncoated tablet contains:- Paracetamol
Excipients
Approved colour used |
IP |
500 mg q.s. |
| 451 |
Paracetamol, Phenylephrine HCL & Chlorpheniramine Maleate Tablets |
Each uncoated tablet contains: Paracetamol Phenylephrine HCL Chlorpheniramine Maleate Excipients Approved colour used. |
IP IP IP |
500mg 10mg 2mg q.s. |
| 452 |
Paracetamol, Phenylephrine HCL,
Chlorpheniramine Maleate, Sodium Citrate & Menthol Suspension |
Each 5ml Contains:- Paracetamol Phenylephrine HCL Chlorpheniramine Maleate Sodium Citrate
Menthol
In flavoured Syrupybase Approved colour used |
IP IP IP IP IP |
250 mg
5 mg
0.5 mg
60 mg
1 mg q.s. |
| 453 |
Paracetamol, Phenylephrine HCL,Caffeine , & Chlorpheniramine Maleate Tablets |
Each uncoated tablet contains: Paracetamol
Phenylephrine Hydrochloride Caffeine (Anhydrous) Chlorpheniramine Maleate Excipients
Approved colour used |
IP IP IP IP |
500 mg
12.5 mg 30mg 2 mg q.s |
| 454 |
Paracetamol, Phenylephrine Hydrochloride , Guaiphenesin, Cetirizine Hydrochloride & Ambroxol Hydrochloride Tablets |
Each uncoated Tablet contains: Paracetamol
Phenylephrine Hydrochloride Guaiphenesin
Cetirizine Hydrochloride Ambroxol Hydrochloride Excipients
Approved colour used. |
IP IP IP IP IP |
325mg 5mg 50mg 5mg 15mg q.s. |
| 455 |
Paracetamol, Phenylephrine Hydrochloride, Cetirizine Hydrochloride , Dextromethorphan Hydrobromide &
Caffeine Tablets |
Each uncoatedtablet contains : Paracetamol
Phenylephrine Hydrochloride Cetirizine Hydrochloride Dextromethorphan Hydrobromide Caffeine (Anhydrous)
Excipients
Approved colour used. |
IP IP IP IP IP |
500mg 10mg 5mg 10mg 30mg q.s. |
| 456 |
Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Maleate &Caffeine Tablets |
Each uncoated Tablet contains: Paracetamol
Phenylephrine Hydrochloride Chlorpheniramine Maleate Caffeine (Anhydrous) Excipients
Approved Colour Used. |
IP IP IP IP |
325mg 5mg 2mg 15mg q.s. |
| 457 |
Paracetamol, Phenylephrine Hydrochloride, Diphenhydramine Hydrochloride & Caffeine (Anhydrous)
Tablets |
Each uncoated tablet contains:- Paracetamol
Phenylephrine Hydrochloride Diphenhydramine Hydrochloride Caffeine (Anhydrous) Excipients
Colour:- Approved colour used |
IP IP IP IP |
500 mg
5 mg
25 mg
30 mg q.s. |
| 458 |
Paracetamol, Phenylpherine Hydrochloride, Caffeine & Diphenhydramine Hydrochloride Tablets |
Each uncoated tablet contains:
Paracetamol
Phenylpherine Hydrochloride Caffeine (Anhydrous) Diphenhydramine Hydrochloride Excipients
Approved colour used. |
IP IP IP IP |
325mg 5mg 30mg 25mg q.s. |
| 459 |
Paroxetine Hydrochloride Tablet |
Each film coated Tablet Contains : Paroxetinehydrochloride Hemihydrate Equ. To Paroxetine
Excipients
Approved Colour used |
IP |
20mg q.s |
| 460 |
Paroxetine Prolonged Release tablet |
Each enteric?oated Bilayered prolonged release Tablet contains :
Paroxetine Hydrochloride (as Hemihydrate) Equ. To Paroxetine
Excipients
Approved colour used |
IP |
12.5mg q.s |
| 461 |
Paroxetine Prolonged- Release Tablets IP |
Each enteric coated prolonged-release tablet contains:
Paroxetine Hydrochloride Hemihydrate Eq.to Paroxetine
Excipients
Approved colour used |
IP |
12.5mg |
| 462 |
Phenylephrine Hydrochloride and Chlorpheniramine
MaleateDrops IP |
Each ml contains : Phenylephrine Hydrochloride Chlorpheniramine Maleate In a flavoured syrupyBase.Approved colour used. |
IP IP |
5mg 2mg q.s. |
| 463 |
Phenylephrine Hydrochloride, Dextromethorphan Hydrobromide, Cetirizine Hydrochloride, Ambroxol Hydrochloride, Guaiphenesin
Tablets |
Each uncoated Tablet Contains : Phenylephrine Hydrochloride Dextromethorphan Hydrochloride Cetirizine Hydrochloride Ambroxol Hydrochloride Guaiphenesin
Excipients
Approved colour used. |
IP IP IP IP IP |
15mg 10mg 5mg 30mg 100mg q.s. |
| 464 |
Phenytoin Tablets IP |
Each film coated tablet contains:- Phenytoin Sodium
Excipients
Colour : Approved Coloured Used |
IP |
100 mg q.s. |
| 465 |
Piracetam & CiticolineTablet s |
Each film coatedtablet contain: Piracetam
Citicoline Sodium Eq. to Citicoline Excipients
Approved colour used |
IP IP |
400 mg
500 mg q.s. |
| 466 |
Piracetam Tablets |
Each film coated tablet contains: Piracetam
Excipients
Approved colour used |
IP |
800 mg q.s. |
| 467 |
Piracetam Tablets IP |
Each film coatedtablet contain: Piracetam
Excipients
Approved colour used |
IP |
400 mg q.s. |
| 468 |
Piroxicame DispersibleTablets |
Each uncoated dispersible tablet contains: Piroxicame
Excipients
Approved colour used |
IP |
20 mg q.s. |
| 469 |
Potassium Citrate, Magnesium Citrate & Vitamin B6 Oral Solution |
Each 5ml contains : Potassium Citrate Magnesium Citrate Pyridoxine Hydrochloride In a Flavoured SyrupyBase Approved colour used |
IP USP IP |
1100mg 375mg 20mg q.s. |
| 470 |
Povidone Iodine Germicide Gargle |
Composition:
Povidone Iodine
(0.2%w/v Available Iodine) Absolute alcohol contain
In a mint Flavour aqueous base |
IP |
2.0% w/v
8.38% v/v q.s. |
| 471 |
Povidone Iodine Solution IP |
Composition :
Povidone Iodine (available Iodine0.5%w/v) Purified Water |
IP
IP |
5%w/v
q.s |
| 472 |
Prasugrel Hydrochloride Tablets |
Each Film coated Tablet Contains : Prasugrel Hydrochloride
Equ. To Prasugrel Excipients
Approved colour used. |
|
5mg q.s. |
| 473 |
Prasugrel Hydrochloride Tablets |
Each Film coated Tablet Contains : Prasugrel Hydrochloride
Equ. To Prasugrel Excipients
Approved colour used. |
|
10mg q.s. |
| 474 |
Prazosin Tablets IP |
Each uncoated tablet contains:
Prazosin Hydrochloride Eq.to Prazosin Excipients
Approved colour used. |
IP |
5mg q.s. |
| 475 |
Prednisolone Tablet IP |
Each uncoated Tablet contains: Prednisolone
Excipients
Colour : Approved Coloured Used |
IP |
5mg q.s |
| 476 |
Prednisolone Tablet IP |
Each uncoated Tablet contains: Prednisolone
Excipients
Colour : Approved Coloured Used |
IP |
10mg q.s |
| 477 |
Prednisolone Tablet IP |
Each uncoated Tablet contains Prednisolone
Excipients
Colour : Approved Coloured Used |
IP |
20mg q.s |
| 478 |
Pregabalin (SR), Methylcobalamin & Nortriptyline Tablets |
Each film coated Tablet Contains: Nortriptyline Hydrochloride Equivalent to Nortriptyline Pregabalin
(as Sustained Release) Methylcobalamin Excipient
Approved colour used |
IP IP IP |
10 mg
75 mg
1500mcg q.s. |
| 479 |
Pregabalin (Sustained Release) & Methylcobalamin Tablets |
Each film coated Bilayered Tablet Contains:
Pregabalin
( As Sustained Release) Methylcobalamin Excipients
Approved Colour Used. |
IP IP |
75mg
1500mcg q.s. |
| 480 |
Pregabalin Sustained Release Tablet |
Each Uncoated Sustained Release Tablet Contains : Pregabalin
Excipients
Approved colour used |
IP |
75mg q.s. |
| 481 |
Pregabalin, Methylcobalamin, Alpha Lipoic Acid, Folic acid & Pyridoxine Tablets |
Each film coated Tablet contains : Pregabalin
Methylcobalamin Alpha Lipoic Acid Folic Acid
Pyridoxine hydrochloride Excipients
Approved colour used |
IP IP USP IP IP |
75mg 1500mcg 100mg 1.5mg 3mg
q.s |
| 482 |
Pregabalin( Sustained Release) & Methylcobalamin Tablets |
Each film coated Tablet Contains:
Pregabalin
( As Sustained Release) Methylcobalamin Excipients
Approved Colour Used. |
IP IP |
75mg
1500mcg q.s. |
| 483 |
Prochlorperazine Maleate Mouth Dissolving Tablets |
Each uncoated Tablet contains: Prochlorperazine Maleate Excipients |
IP |
5mg q.s. |
| 484 |
Propranolol Hydrochloride (SR) & Flunarizine Tablets |
Each Uncoated Bilayered Tablet Contains:
Propranolol Hydrochloride (as Sustained Release) Flunarizine Dihydrochloride Equ. To Flunarizine Excipients
Approved colour used. |
IP BP |
40mg
10mg q.s. |
| 485 |
Propranolol Hydrochloride Tablets |
Each Uncoated Tablet Contains: Propranolol Hydrochloride Excipients |
IP |
40mg q.s. |
| 486 |
Protein Hydrolysate, Calcium, Phosphorus, Vitamin B6, Cyanocobalamin Vitamin D3, Niacinamide, Folic Acid, Zinc & Iron |
Each 30g contains:
Protein hydrolysate 20%
Calcium
(as Dibasic Calcium Phosphate)
Phosphorus
(as Dibasic Calcium Phosphate) Vitamin B6 (Pyridoxine Hydrochloride) Vitamin B12 (Cyanocobalamin) Vitamin D3
Niacinamide Folic Acid Zinc
(as ZincSulphate Heptahydrate IP)
Iron
(as Ferric Ammonium Citrate IP) Excipients |
IP
IP IP IP IP IP IP |
5 g
225 mg
174 mg
0.5 mg
1 mcg
100 IU
15 mg
300 mg
5 mg
7.5 mg q.s. |
| 487 |
Prulifloxacin Tablets |
Each film coated Tablet Contains: Prulifloxacin
Excipients
Approved Colour used |
|
600mg |
| 488 |
Pyridoxine Hydrochloride Tablets IP |
Each uncoated Tablet Contains: Pyridoxine Hydrochloride Excipients |
IP |
50mg q.s. |
| 489 |
Rabeprazole & Domperidone Tablets |
Each enteric coated tablets contains: Rabeprazole Sodium
Domperidone Excipients
Colour:- Approved colour used |
IP IP |
20 mg
10 mg q.s |
| 490 |
Rabeprazole Gastro- Resistant Tablets IP |
Each enteric coated tablets contains: Rabeprazole Sodium
Excipients
Colour:- Approved colour used |
IP |
20mg q.s |
| 491 |
Ramipril & Hydrochlorothiazid e Tablets IP |
Each uncoated Tablet Contains: Ramipril
Hydrochlorthiazide Excipients
Approved colour used |
IP IP |
2.5mg 12.5mg q.s. |
| 492 |
Ramipril & Hydrochlorothiazid e Tablets IP |
Each uncoated Tablet Contains: Ramipril
Hydrochlorthiazide Excipients
Approved colour used |
IP IP |
5mg 12.5mg q.s. |
| 493 |
Ramipril Tablets IP |
Each Uncoated Tablet Contains: Ramipril
Excipients |
IP |
2.5mg q.s. |
| 494 |
Ramipril Tablets IP |
Each uncoated Tablet Contains: Ramipril
Excipients
Approved colour used |
IP |
1.25 mg q.s. |
| 495 |
Ramipril Tablets IP |
Each uncoated Tablet Contains: Ramipril
Excipients
Approved colour used |
IP |
5mg q.s. |
| 496 |
Ranitidine Hydrochloride Tablets |
Each film coated Tablet contains: Ranitidine Hydrochloride
Equ. To Ranitidine Excipients
Approved colour used. |
IP |
150mg q.s |
| 497 |
Ranitidine Hydrochloride Tablets |
Each film coated Tablet contains: Ranitidine Hydrochloride
Equ. To Ranitidine Excipients
Approved colour used. |
IP |
300mg q.s |
| 498 |
Riboflavin , Folic Acid, Niacinamide & Lactic Acid Bacillus Tablets |
Each Uncoated Tablet contains: Riboflavin
Folic acid Niacinamide Lacticacid bacillus Excipients
Colour: Tartrazine |
IP IP IP |
10mg 1.5mg 100mg 60Million Spores q.s |
| 499 |
Riboflavin, Folic Acid, Niacinamide with Lactic Acid Bacillus Tablets |
Each uncoated Tablet Contains: Riboflavin
Folic Acid Niacinamide
Lactic Acid Bacillus Excipients
Approved colour used. |
IP IP IP |
10mg 1.5mg 50mg
120 Million spores
q.s. |
| 500 |
Rifaximin Tablets |
Each film coatedtablets contains: Rifaximin
Excipients
Approved colour used |
|
550 mg q.s. |
| 501 |
Rifaximin Tablets |
Each film coated tablets contains: Rifaximin
Excipients
Approved colour used |
|
400 mg q.s. |
| 502 |
Rifaximine Tablets |
Each film coated tablets contains: Rifaximine
Excipients
Approved colour used |
|
200 mg q.s. |
| 503 |
Rosuvastatin & FenofibrateTablets |
Each film coated Tablet Contains: Rosuvastatin Calcium
Equ. To Rosuvastatin Fenofibrate Excipients
Approved colour used |
IP IP |
20mg 160mg q.s. |
| 504 |
Rosuvastatin & FinofibrateTablet IP |
Each film coated tablet contains:- Rosuvastatin calcium
Equ. to Rosuvastatin Finofibrate Excipients
Colour : Approved Coloured Used |
IP IP |
10mg 160mg
q.s. |
| 505 |
Rosuvastatin Tablet IP |
Each film coated tablet Contains : Rosuvastatin Calcium
Equ. To Rosuvastatin Excipients
Approved Colour Used |
IP |
40mg |
| 506 |
Rosuvastatin Tablets IP |
Each filmcoated tablet contain Rosuvastatin Calcium
Eq.to Rosuvastatin Excipients
Approved colour used |
IP |
5 mg q.s. |
| 507 |
Rosuvastatin Tablets IP |
Each filmcoated tablet contain Rosuvastatin calcium
Eq.to Rosuvastatin Excipients
Approved colour used |
IP |
10 mg q.s. |
| 508 |
Rosuvastatin Tablets IP |
Each filmcoated tablet contain Rosuvastatin Calcium
Eq.to Rosuvastatin Excipients
Approved colour used |
IP |
20 mg q.s. |
| 509 |
Roxithromycin & Ambroxol Tablets |
Each film coatedtablet contain: Roxithromycin
Ambroxol Hydrochloride Excipients
Approved colour used |
IP IP |
150 mg
60 mg q.s |
| 510 |
Roxithromycin Tablets |
Each film coated tablets contains: Roxithromycin
Excipients
Approved colour used |
IP |
150 mg q.s. |
| 511 |
Serratiopeptidase tablet IP |
Each film coated tablet Contains :-
Serratiopeptidase
(Equ. to Enzyme activity20,000Units of enteric coated granules)
Excipients
Colour : Approved Colour Used |
IP |
10mg q.s. |
| 512 |
Sertraline Hydrochloride Tablets IP |
Each film coated Tablet Contains: Sertraline Hydrochloride
Equ. To Sertraline Excipients
Approved Colour used. |
IP |
50mg q.s. |
| 513 |
Sertraline Tablets IP |
Each film coated tablets contains: Sertraline Hydrochloride Eq. to Sertraline Excipients Approved colour used. |
IP |
25mg q.s. |
| 514 |
Sevelamer CarbonateTablets |
Each film coated Tablet Contains: Sevelamer Carbonate
Excipients
Approved colour used |
|
400mg q.s. |
| 515 |
Sildenafil Citrate Tablets IP |
Each film coated tablet contains:- Sildenafil Citrate
Eq. to sildenafil Excipients
Colour:- Approved Colour used |
IP |
50 mg q.s. |
| 516 |
Sildenafil Citrate Tablets IP |
Each film coated tablet contains:- Sildenafil Citrate
Eq. to sildenafil Excipients
Colour:- Approved Colour used |
IP |
100 mg q.s. |
| 517 |
Sitagliptin Phosphate & Metformin Hydrochloride
Tablets |
Each film coated Tablets contains : Sitagliptin Phosphate Monohydrate Equ. To Sitagliptin Metformin Hydrochloride Excipients Approved colour used. |
IP |
64.25mg
50mg 500mg q.s. |
| 518 |
Sitagliptin Phosphate & Metformin Hydrochloride Tablets |
Each film coated Tablets contains : Sitagliptin Phosphate Monohydrate Equ. To Sitagliptin
Metformin Hydrochloride Excipients
Approved colour used |
IP |
64.25mg
50mg 1000mg q.s. |
| 519 |
Sitagliptin Phosphate & Metformin Hydrochloride Tablets |
Each film coated Tablet Contains : Sitagliptin Phosphate Monohydrate Equ. To Sitagliptin
Metformin Hydrochloride Excipients
Approved colour used. |
IP IP |
64.25mg
50mg 850mg q.s. |
| 520 |
Sitagliptin PhosphateTablet |
Each film coated Tablet Contains : Sitagliptin phosphate Monohydrate Equ. To Sitagliptin
Excipients
Approved Colour used |
IP |
25mg q.s |
| 521 |
Sitagliptin PhosphateTablet |
Each film coated Tablet Contains : Sitagliptin phosphate Monohydrate Equ. To Sitagliptin
Excipients
Approved Colour used |
IP |
50mg q.s |
| 522 |
Sitagliptin PhosphateTablet |
Each film coated Tablet Contains : Sitagliptin phosphate Monohydrate Equ. To Sitagliptin
Excipients
Approved Colour used |
IP |
100mg q.s |
| 523 |
Sodium Valproate & Valproic Acid Controlled ReleaseTablet |
Each film coated controlledrelease tablet contains: Sodium Valproate
Valproic Acid
(Both together correspond tosodium valproate) Excipients
Approved colour used |
IP IP |
133.5 mg
58 mg
200 mg q.s. |
| 524 |
Sodium Valproate & Valproic Acid Controlled ReleaseTablet |
Each film coated controlledrelease tablet contains: Sodium Valproate
Valproic Acid
(Both together correspond tosodium valproate) Excipients
Approved colour used |
IP IP |
333 mg
145 mg
500 mg q.s. |
| 525 |
Solifenacin Succinate Tablets IP |
Each film coated tablet contains:
Solifenacin Succinate Excipients
Approved colour used. |
IP |
5mg q.s. |
| 526 |
Spironolactone Tablets IP |
Each Uncoated Tablet Contains: Spironolactone
Excipients
Approved colour used |
IP |
25mg q.s. |
| 527 |
Spironolactone Tablets IP |
Each Uncoated Tablet Contains: Spironolactone
Excipients
Approved colour used |
IP |
50mg q.s. |
| 528 |
Spironolactone Tablets IP |
Each Uncoated Tablet Contains: Spironolactone
Excipients
Approved colour used |
IP |
100mg q.s. |
| 529 |
Sulfasalazine Gastro ?Resistant Tablets IP |
Each enteric coated tablet contains: Sulfasalazine
Excipients
Approved colour used. |
IP |
500mg q.s. |
| 530 |
Sulfasalazine Gastro Resistant Tablets USP |
Each Enteric Coated Tablet Contains: Sulfasalazine
Excipients
Approved colour used |
USP |
1000mg q.s. |
| 531 |
Tadalafil Tablet IP |
Each uncoated tablet contains: Tadalafil
Excipients
Approved colour used |
IP |
10 mg q.s |
| 532 |
Tadalafil Tablet IP |
Each uncoated tablet contains: Tadalafil
Excipients
Approved colour used |
IP |
20 mg q.s |
| 533 |
Tamsulosin Hydrochloride (MR) & Dutasteride Tablets |
Each film coated Tablet contains:
Tamsulosin Hydrochloride (as modified release) Dutasteride
Excipients
Approved colour used. |
IP IP |
0.4 mg
0.5 mg q.s. |
| 534 |
Tamsulosin Hydrochloride Modified Release Tablets |
Each film coated Tablet contains:
Tamsulosin Hydrochloride (as modified release) Excipients
Approved colour used. |
IP |
0.4mg q.s. |
| 535 |
Tapentadol Tablets |
Each film coatedtablet contain: Tapentadol Hydrochloride Equivalent to Tapentadol Excipients
Approved colour used |
IP |
50 mg q.s. |
| 536 |
Tapentadol Tablets |
Each film coatedtablet contain: Tapentadol Hydrochloride Equivalent to Tapentadol Excipients
Approved colour used |
IP |
100 mg q.s. |
| 537 |
Telmisartan & AmlodipineTablets |
Each uncoated Bilayered Tablet Contains: Telmisartan
Amlodipine Besylate Equ. To Amlodipine Excipients
Approved colour used. |
IP IP |
80mg
5mg q.s. |
| 538 |
Telmisartan & AmlodipineTablets IP |
Each Uncoated Tablet Contains :- Telmisartan
Amlodipine Besylate Equ. To Amlodipine Excipients
Colour: Approved Colour Used. |
IP IP |
40mg
5mg q.s. |
| 539 |
Telmisartan & AmlodipineTablets IP |
Each Uncoated Tablet Contains:- Telmisartan Amlodipine Besylate Equ. To Amlodipine "Excipients Colour: Approved Coloured Used. |
IP IP |
80mg 10mg q.s |
| 540 |
Telmisartan & AmlodipineTablets IP |
Each Uncoated Tablet Contains :- Telmisartan
Amlodipine Besylate Equ. To Amlodipine Excipients
Approved Colour Used. |
IP IP |
80mg
5mg q.s. |
| 541 |
Telmisartan & AmlodipineTablets IP |
Each Uncoated Bilayered Tablet Contains :- Telmisartan
Amlodipine Besylate Equ. To Amlodipine Excipients
Colour: Approved Colour Used. |
IP IP |
40mg
5mg q.s. |
| 542 |
Telmisartan & AmlodipineTablets IP |
Each Uncoated Bilayered Tablet Contains:- Telmisartan
Amlodipine Besylate
Equ. To Amlodipine Excipients
Colour: Approved Coloured Used. |
IP IP |
80mg
10mg q.s |
| 543 |
Telmisartan & Atorvastatin Tablets |
Each film coated Tablet Contains : Telmisartan
Atorvastatin Calcium Equ. To Atorvastatin. Excipients
Approved colour used. |
IP IP |
40mg
10mg q.s. |
| 544 |
Telmisartan & Chlorthalidone Tablets |
Each uncoated Bilayered Tablet contains: Telmisartan
Chlorthalidone Excipients
Approved colour used. |
IP IP |
40mg 12.5mg q.s. |
| 545 |
Telmisartan & CilnidipineTablets |
Each Film coated Tablet Contains : Telmisartan
Cilnidipine Excipients
Approved colour used. |
IP IP |
40mg 10mg q.s. |
| 546 |
Telmisartan & Hydrochlorthiazide Tablet IP |
Each Uncoated Tablet Contains:- Telmisartan
Hydrochlorothiazide Excipients
Colour: Approved Coloured Used. |
IP IP |
80mg 12.5mg q.s |
| 547 |
Telmisartan & Metoprolol Succinate (ER) Tablets |
Each uncoated bilayer tablet contain: Telmisartan
Metoprolol Succinate
Eq. to Metoprolol Tartrate (As Extended Release) Excipients
Approved colour used |
IP IP |
40 mg
47.5 mg
50 mg q.s. |
| 548 |
Telmisartan & Metoprolol Succinate (ER) Tablets |
Each Uncoated Bilayered Tablet Contains: Telmisartan
Metoprolol Succinate Equ. To Metoprolol Tartrate(as Extended Release ) Excipients Approved colour used |
IP IP IP |
40mg 23.75
25mg q.s. |
| 549 |
Telmisartan and Hydrochlorothiazid e
Tablets IP |
Each Uncoated Tablet Contains:- Telmisartan
Hydrochlorothiazide Excipients
Colour: Approved Colour Used. |
IP IP |
40mg 12.5mg q.s. |
| 550 |
Telmisartan Tablet IP |
Each Uncoated Tablet Contains:- Telmisartan
Excipients
Colour: Approved Colour Used. |
IP |
20mg q.s |
| 551 |
Telmisartan Tablet IP |
Each Uncoated Tablet Contains:- Telmisartan
Excipients
Colour: Approved Colour Used. |
IP |
40mg q.s |
| 552 |
Telmisartan Tablet IP |
Each Uncoated Tablet Contains:- Telmisartan
Excipients
Colour: Approved Colour Used. |
IP |
80mg q.s |
| 553 |
Telmisartan, Amlodipine & Hydrochlorothiazid e |
Each uncoated bilayer tablet contain: Telmisartan
Amlodipine Besylate Eq.to Amlodipine Hydrochlorothiazide Excipients
Approved colour used |
IP IP
IP |
40 mg
5 mg
12.5 mg |
| 554 |
Teneligliptin & Metformin hydrochloride Tablets |
Each uncoated by-layered tablets contains: Teneligliptin hydrobromide hydrat Equivalent to Teneligliptin
Metformin hydrochloride (As Extended release) Excipients
Approved colour used |
IP |
20 mg
500 mg q.s. |
| 555 |
Teneligliptin & Metformin Hydrochloride Tablets |
Each uncoated bilayered tablet contains: Teneligliptin Hydrobromide hydrate Equivalent to Teneligliptin
Metformin hydrochloride (As Extended release) Excipients
Approved colour used |
IP |
20 mg
1000 mg
q.s. |
| 556 |
Terbinafine hydrochloride Tablets IP |
Each film coated tablets contains: Terbinafine hydrochloride Equivalent to Terbinafine Excipients
Approved colour used |
IP |
250 mg q.s. |
| 557 |
Terbinafine hydrochloride Tablets IP |
Each film coated tablets contains: Terbinafine hydrochloride Equivalent to Terbinafine Excipients
Approved colour used |
IP |
500 mg q.s. |
| 558 |
Terbutaline Sulphate, Ambroxol HCl, Guaiphenesin & Menthol Expectorant |
Each 5ml contains : Terbutaline Sulphate Ambroxol Hydrochloride Guaiphenesin Menthol Flavoured SyrupyBase Approved colour used. |
IP IP IP IP |
1.5mg 15mg 50mg 1.5mg q.s. |
| 559 |
Thiamine Hydrochloride Tablets IP |
Each film coated Tablet Contains: Thiamine Hydrochloride Excipients
Approved colour used |
IP |
100mg q.s. |
| 560 |
Thiamine Tablets IP |
Each uncoated Tablet Contains Thiamine Hydrochloride Excipients
Colour :- Approved colour used |
IP |
50mg q.s |
| 561 |
Thyroxine Tablet IP |
Each Uncoated Tablet Contains Thyroxine sodium
(as anhydrous) Excipients
Colour : Approved Coloured Used |
IP |
12.5mcg q.s |
| 562 |
Thyroxine Tablet IP |
Each Uncoated Tablet Contains Thyroxine sodium
(as anhydrous) Excipients
Colour : Approved Coloured Used |
IP |
25mcg q.s |
| 563 |
Thyroxine Tablet IP |
Each Uncoated Tablet Contains Thyroxine sodium
(as anhydrous) Excipients
Colour : Approved Coloured Used |
IP |
50mcg q.s |
| 564 |
Thyroxine Tablet IP |
Each Uncoated Tablet Contains Thyroxine sodium
(as anhydrous) Excipients
Colour : Approved Coloured Used |
IP |
75mcg q.s |
| 565 |
Thyroxine Tablet IP |
Each Uncoated Tablet Contains Thyroxine sodium
(as anhydrous) Excipients
Colour : Approved Coloured Used |
IP |
100 mcg q.s |
| 566 |
Ticagrelor Tablets |
Each film coated tablet contains: Ticagrelor
Excipients
Approved colour used |
IP |
90mg q.s |
| 567 |
Tolperisone Hydrochloride & Diclofenac Sodium Tablets |
Each Film coated Tablets Contains : Tolperisone Hydrochloride Diclofenac Sodium
Excipients
Approved colour used |
JP IP |
150mg 50mg q.s. |
| 568 |
Tolperisone Hydrochloride & Paracetamol Tablet |
Each film coated Tablet Contains: Tolperisone hydrochloride Paracetamol
Excipients
Approved colour Used |
JP IP |
150mg 325mg |
| 569 |
Tolperisone Hydrochloride Sustained Release Tablet |
Each film coated sustained Release Tablet Contains: Tolperisone Hydrochloride
Excipients
Approved Colour Used |
JP |
450mg |
| 570 |
Tolperisone Hydrochloride Tablet |
Each film coated Tablet Contains: Tolperisone Hydrochloride Excipients
Approved colour used |
JP |
150mg q.s |
| 571 |
Torsemide & Spironolactone Tablets |
Each uncoated tablet contain: Torsemide Spironolactone Excipients Approved colour used |
IP IP |
10 mg
50 mg q.s. |
| 572 |
Torsemide & Spironolactone Tablets |
Each uncoated tablet contain: Torsemide
Spironolactone Excipients
Approved colour used |
IP IP |
20 mg
50 mg q.s. |
| 573 |
Torsemide & Spironolactone Tablets |
Each uncoated tablet contains: Torsemide
Spironolactone Excipients
Approved colour used |
IP IP |
q mg 50 mg q.s. |
| 574 |
Torsemide Tablets IP |
Each uncoated tablet contain: Torsemide
Excipients
Approved colour used |
IP |
10 mg q.s. |
| 575 |
Torsemide Tablets IP |
Each uncoated tablet contain: Torsemide
Excipients
Approved colour used |
IP |
20 mg q.s. |
| 576 |
Torsemide Tablets IP |
Each uncoated tablet contain: Torsemide
Excipients
Approved colour used |
IP |
5 mg q.s. |
| 577 |
Torsemide Tablets IP |
Each uncoated tablet contain: Torsemide
Excipients
Approved colour used |
IP |
100 mg q.s. |
| 578 |
Tramadol Hydrochloride Prolonged Release Tablet IP |
Each film coated sustainedrelease tablet contain: Tramadol Hydrochloride
Excipients
Approved colour used |
IP |
100mg q.s |
| 579 |
Tramadol Hydrochloride Tablet IP |
Each film coatedtablet contain: Tramadol Hydrochloride Excipients
Approved colour used |
IP |
100mg q.s |
| 580 |
Tranexamic Acid & Ethamsylate Tablets |
Each film coated Tablet contains: Tranexamic Acid
Ethamsylate Excipients
Approved colour used. |
IP BP |
250mg 250mg q.s. |
| 581 |
Tranexamic Acid & Mefenamic Acid Tablets |
Each film coated tablets contains: Tranexamic Acid
Mefenamic Acid Excipients
Approved colour used |
IP IP |
500 mg
250 mg q.s. |
| 582 |
Tranexamic Acid Tablets IP |
Each film coated Tablet Contains: Tranexamic Acid
Excipients
Approved Colour Used. |
IP |
500mg |
| 583 |
Tranexamic Acid Tablets IP (Correctain done in new Permission
18/12/2024) |
Each film coated Tablet Contains: Tranexamic Acid
Excipients
Colour : Approved Coloured Used |
IP |
250mg q.s |
| 584 |
Trifluoperazine Hydrochloride Tablets IP |
Each film coated Tablet contains: Trifluoperazine Hydrochloride Excipients
Approved colour used |
IP |
5mg q.s |
| 585 |
Trypsin , Bromelain and Rutoside Trihydrate Tablets |
Each Enteric coated tablet contains: Trypsin
Bromelain RutosideTrihydrate Excipients
Approved colour used. |
BP BP |
96mg 180mg 200mg q.s. |
| 586 |
Trypsin ?Chymotrypsin Tablets |
Each enteric ?coated tablet contains:
2,00,000 Armour Units of Enzymatic Activity*
*Supplied by a purified Concentrate which has Specific Trypsin and Chymotrypsin Activity in a Ratio of Approximately Six to One.
Excipients
Approved colour used. |
|
2,00,000 AU
q.s. |
| 587 |
Trypsin- Chymotrypsin Tablets |
Each entericcoated Tablet contains: 1,00,000 Armour units of enzymaticactivity *Supplied by a purified concentrate which has specific Trypsin & Chymotrypsin activityin aratio of Approximately six to one. Excipients Approved colour used." |
q.s. |
|
| 588 |
Trypsin-Chymotrypsin, Aceclofenac & Paracetamol Tablets |
Each film coated tablet contains: Aceclofenac Paracetamol Trypsin-Chymotrypsin Of enzyme activity (as enteric coated granules) Excipients Approved colour used. |
IP IP |
100mg 325mg 150,000AU q.s. |
| 589 |
Trypsin, Bromelain & Rutoside Trihydrate Tablets |
Each Enteric coated Tablet Contains:- Trypsin
Bromelain RutosideTrihydrate
Equivalent to Rutoside (anhydrous) Excipients
Approved colour used |
BP BP |
48 mg
90 mg
100 mg q.s. |
| 590 |
Trypsin, Bromelain, Rutoside Trihydrate & Diclofenac Sodium Tablets |
Each Enteric coated Tablet Contains : Trypsin
Bromelain
Rutoside Trihydrate Diclofenac Sodium Excipients
Approved Colour Used. |
BP
BP IP |
48mg 90mg 100mg 50mg q.s. |
| 591 |
Trypsin, Bromelain, Rutoside Trihydrate and Aceclofenac
Tablets |
Each enteric coated Tablet contains : Trypsin Bromelain Rutoside Trihydrate "Aceclofenac Excipients Approved colour used" |
IP BP IP |
48mg 90mg 100mg 100mg q.s |
| 592 |
Ursodeoxycholic Acid Tablets IP |
Each film coated tablets contains: Ursodeoxycholic Acid Excipients
Approved colour used |
IP |
300 mg q.s. |
| 593 |
Ursodeoxycholic Acid Tablets IP |
Each film coated tablets contains: Ursodeoxycholic Acid Excipients
Approved colour used |
IP |
150 mg q.s. |
| 594 |
Vildagliptin & Metformin Hydrochloride Tablet |
Each film coated tablet contains: Vildagliptin
Metformin Hydrochloride Excipients
Approved colour used |
IP |
50 mg
500 mg q.s. |
| 595 |
Vildagliptin & Metformin Hydrochloride Tablet |
Each film coated tablet contains: Vildagliptin
Metformin Hydrochloride Excipients
Approved colour used |
IP |
50 mg
1000 mg q.s. |
| 596 |
Vildagliptin Tablet |
Each uncoated tablet contains: Vildagliptin
Excipients
Approved colour used |
|
50 mg q.s. |
| 597 |
Vitamin D3 oral solution |
Each 5 ml contains:
Cholecalciferol
(In Nano Droplet form)
In a flavoured sugar free syrupybase. Approved colour used. |
IP |
60000IU
q.s |
| 598 |
Vitamin E Acetate & Levocarnitine Tablets |
Each film coated tablet contains: Tocopheryl Acetate (as 50% powder) L- Carnitine ? ?Tartrate Eq. to Levocarnitine Appropriate overages added Excipients Approved colour used. |
IP USP |
200mg
150mg q.s |
| 599 |
Voglibose & Metformin Hydrochloride (Sustained Release) Tablet |
Each uncoated Bilayered tablet contains: Voglibose
Metformin Hydrochloride (As Sustained Release) Excipients
Approved colour used |
IP IP |
0.2 mg
500 mg q.s. |
| 600 |
Voglibose & Metformin Hydrochloride (Sustained Release) Tablet |
Each uncoated Bilayered tablet contains: Voglibose
Metformin Hydrochloride (As Sustained Release) Excipients
Approved colour used |
IP IP |
0.3 mg
500mg q.s. |
| 601 |
Voglibose Dispersible Tablet IP |
Each uncoated tablet contains: Voglibose
Excipients
Approved colour used |
IP |
0.2 mg q.s. |
| 602 |
Voglibose Dispersible Tablet IP |
Each uncoated tablet contains: Voglibose
Excipients
Approved colour used |
IP |
0.3 mg q.s. |
| 603 |
Voglibose, Glimepiride & Metformin Hydrochloride (Sustained Release) Tablet |
Each uncoated Bilayered tablet contains: Voglibose
Glimepiride
Metformin Hydrochloride (As Sustained Release) Excipients
Approved colour used |
IP IP IP |
0.2 mg
1 mg
500mg q.s. |
| 604 |
Voglibose, Glimepiride & Metformin Hydrochloride (Sustained Release) Tablet |
Each uncoated Bilayered tablet contains: Voglibose
Glimepiride
Metformin Hydrochloride (As Sustained Release) Excipients
Approved colour used |
IP IP IP |
0.2 mg
2 mg
500mg
q.s. |
| 605 |
Voglibose, Glimepiride & Metformin Hydrochloride (Sustained Release) Tablet |
Each uncoated Bilayered tablet contains: Voglibose
Glimepiride
Metformin Hydrochloride (As Sustained Release) Excipients
Approved colour used |
IP IP IP |
0.3 mg
2 mg
500mg q.s. |
| 606 |
Voriconazole Tablet IP |
Each film coated Tablet Contains: Voriconazole
Excipients
Approved Colour Used. |
IP |
200 mg q.s |
| 607 |
Warfarin Sodium Tablets IP 1mg |
Each uncoated tablet contains: Warfarin Sodium Clathrate Eq. to Warfarin Sodium (anhydrous)
Excipients
Approved Colour used |
IP |
1mg q.s. |
| 608 |
Warfarin Sodium Tablets IP 3mg |
Each uncoated tablet contains: Warfarin Sodium Clathrate Eq. to Warfarin Sodium (anhydrous)
Excipients
Approved Colour used |
IP |
3mg q.s. |
| 609 |
Warfarin Sodium Tablets IP 5mg |
Each uncoated tablet contains: Warfarin Sodium Clathrate Eq. to Warfarin Sodium (anhydrous)
Excipients
Approved Colour used |
IP |
5mg q.s. |
| 610 |
Zinc Acetate Tablets |
Each Entericcoated Tablet Contains: Zinc Acetate(as 65ehydrate)
Equ. toElemental Zinc Excipients
Approved Colour Used |
USP |
50mg q.s |